BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, Peters JA, Harmar AJ; CGTP Collaborators. The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol 2013;170:1459-581. [PMID: 24517644 DOI: 10.1111/bph.12445] [Cited by in Crossref: 504] [Cited by in F6Publishing: 489] [Article Influence: 63.0] [Reference Citation Analysis]
Number Citing Articles
1 Mohammadi M, Fendt M. Relief learning is dependent on NMDA receptor activation in the nucleus accumbens. Br J Pharmacol 2015;172:2419-26. [PMID: 25572550 DOI: 10.1111/bph.13070] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
2 Kurano M, Hara M, Nojiri T, Ikeda H, Tsukamoto K, Yatomi Y. Resveratrol exerts a biphasic effect on apolipoprotein M. Br J Pharmacol 2016;173:222-33. [PMID: 26445217 DOI: 10.1111/bph.13360] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
3 Stanley C, O'Sullivan SE. Vascular targets for cannabinoids: animal and human studies. Br J Pharmacol 2014;171:1361-78. [PMID: 24329566 DOI: 10.1111/bph.12560] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 6.4] [Reference Citation Analysis]
4 Callaghan B, Kosari S, Pustovit RV, Sartor DM, Ferens D, Ban K, Baell J, Nguyen TV, Rivera LR, Brock JA, Furness JB. Hypotensive effects of ghrelin receptor agonists mediated through a novel receptor. Br J Pharmacol 2014;171:1275-86. [PMID: 24670149 DOI: 10.1111/bph.12527] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
5 Chu SC, Chen PN, Hsieh YS, Yu CH, Lin MH, Lin YH, Kuo DY. Involvement of hypothalamic PI3K-STAT3 signalling in regulating appetite suppression mediated by amphetamine. Br J Pharmacol 2014;171:3223-33. [PMID: 24597972 DOI: 10.1111/bph.12667] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
6 Keenan CM, Storr MA, Thakur GA, Wood JT, Wager-Miller J, Straiker A, Eno MR, Nikas SP, Bashashati M, Hu H, Mackie K, Makriyannis A, Sharkey KA. AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally restricted manner. Br J Pharmacol 2015;172:2406-18. [PMID: 25572435 DOI: 10.1111/bph.13069] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
7 Jenkin KA, O'Keefe L, Simcocks AC, Briffa JF, Mathai ML, McAinch AJ, Hryciw DH. Renal effects of chronic pharmacological manipulation of CB2 receptors in rats with diet-induced obesity. Br J Pharmacol 2016;173:1128-42. [PMID: 25537025 DOI: 10.1111/bph.13056] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
8 Huang Y, Thathiah A. Regulation of neuronal communication by G protein-coupled receptors. FEBS Lett 2015;589:1607-19. [PMID: 25980603 DOI: 10.1016/j.febslet.2015.05.007] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 8.7] [Reference Citation Analysis]
9 Massotte D. In vivo opioid receptor heteromerization: where do we stand? Br J Pharmacol 2015;172:420-34. [PMID: 24666391 DOI: 10.1111/bph.12702] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
10 Walford T, Musa FI, Harper AG. Nicergoline inhibits human platelet Ca(2+) signalling through triggering a microtubule-dependent reorganization of the platelet ultrastructure. Br J Pharmacol 2016;173:234-47. [PMID: 26450366 DOI: 10.1111/bph.13361] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
11 McGrath JC. Localization of α-adrenoceptors: JR Vane Medal Lecture. Br J Pharmacol 2015;172:1179-94. [PMID: 25377869 DOI: 10.1111/bph.13008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
12 Lagatta DC, Ferreira-Junior NC, Resstel LB. Medial prefrontal cortex TRPV1 channels modulate the baroreflex cardiac activity in rats. Br J Pharmacol 2015;172:5377-89. [PMID: 26360139 DOI: 10.1111/bph.13327] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
13 Böhmer T, Manicam C, Steege A, Michel MC, Pfeiffer N, Gericke A. The α₁B -adrenoceptor subtype mediates adrenergic vasoconstriction in mouse retinal arterioles with damaged endothelium. Br J Pharmacol 2014;171:3858-67. [PMID: 24749494 DOI: 10.1111/bph.12743] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
14 Natale CA, Duperret EK, Zhang J, Sadeghi R, Dahal A, O'Brien KT, Cookson R, Winkler JD, Ridky TW. Sex steroids regulate skin pigmentation through nonclassical membrane-bound receptors. Elife 2016;5:e15104. [PMID: 27115344 DOI: 10.7554/eLife.15104] [Cited by in Crossref: 54] [Cited by in F6Publishing: 26] [Article Influence: 9.0] [Reference Citation Analysis]
15 Puhl SL, Kazakov A, Müller A, Fries P, Wagner DR, Böhm M, Maack C, Devaux Y. Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to α1 -adrenoceptor stimulation in vivo. Br J Pharmacol 2016;173:88-102. [PMID: 26406609 DOI: 10.1111/bph.13339] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
16 Schulz S, Lehmann A, Kliewer A, Nagel F. Fine-tuning somatostatin receptor signalling by agonist-selective phosphorylation and dephosphorylation: IUPHAR Review 5. Br J Pharmacol 2014;171:1591-9. [PMID: 24328848 DOI: 10.1111/bph.12551] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
17 Muley MM, Reid AR, Botz B, Bölcskei K, Helyes Z, McDougall JJ. Neutrophil elastase induces inflammation and pain in mouse knee joints via activation of proteinase-activated receptor-2. Br J Pharmacol 2016;173:766-77. [PMID: 26140667 DOI: 10.1111/bph.13237] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 5.0] [Reference Citation Analysis]
18 Cook AE, Mistry SN, Gregory KJ, Furness SG, Sexton PM, Scammells PJ, Conigrave AD, Christopoulos A, Leach K. Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics. Br J Pharmacol. 2015;172:185-200. [PMID: 25220431 DOI: 10.1111/bph.12937] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 6.5] [Reference Citation Analysis]
19 Kihara Y, Maceyka M, Spiegel S, Chun J. Lysophospholipid receptor nomenclature review: IUPHAR Review 8. Br J Pharmacol. 2014;171:3575-3594. [PMID: 24602016 DOI: 10.1111/bph.12678] [Cited by in Crossref: 185] [Cited by in F6Publishing: 179] [Article Influence: 23.1] [Reference Citation Analysis]
20 Lacković Z, Filipović B, Matak I, Helyes Z. Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches. Br J Pharmacol 2016;173:279-91. [PMID: 26493010 DOI: 10.1111/bph.13366] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 6.5] [Reference Citation Analysis]
21 O'Callaghan G, Houston A. Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets? Br J Pharmacol 2015;172:5239-50. [PMID: 26377664 DOI: 10.1111/bph.13331] [Cited by in Crossref: 85] [Cited by in F6Publishing: 80] [Article Influence: 12.1] [Reference Citation Analysis]
22 Aguado A, Rodríguez C, Martínez-Revelles S, Avendaño MS, Zhenyukh O, Orriols M, Martínez-González J, Alonso MJ, Briones AM, Dixon DA, Salaices M. HuR mediates the synergistic effects of angiotensin II and IL-1β on vascular COX-2 expression and cell migration. Br J Pharmacol 2015;172:3028-42. [PMID: 25653183 DOI: 10.1111/bph.13103] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
23 Ansell TK, Noble PB, Mitchell HW, McFawn PK. Pharmacological bronchodilation is partially mediated by reduced airway wall stiffness. Br J Pharmacol 2014;171:4376-84. [PMID: 24846164 DOI: 10.1111/bph.12781] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
24 Al-Kofahi M, Becker F, Gavins FN, Woolard MD, Tsunoda I, Wang Y, Ostanin D, Zawieja DC, Muthuchamy M, von der Weid PY, Alexander JS. IL-1β reduces tonic contraction of mesenteric lymphatic muscle cells, with the involvement of cycloxygenase-2 and prostaglandin E2. Br J Pharmacol 2015;172:4038-51. [PMID: 25989136 DOI: 10.1111/bph.13194] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
25 Suen JY, Cotterell A, Lohman RJ, Lim J, Han A, Yau MK, Liu L, Cooper MA, Vesey DA, Fairlie DP. Pathway-selective antagonism of proteinase activated receptor 2. Br J Pharmacol 2014;171:4112-24. [PMID: 24821440 DOI: 10.1111/bph.12757] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 5.4] [Reference Citation Analysis]
26 Roviezzo F, Sorrentino R, Bertolino A, De Gruttola L, Terlizzi M, Pinto A, Napolitano M, Castello G, D'Agostino B, Ianaro A, Sorrentino R, Cirino G. S1P-induced airway smooth muscle hyperresponsiveness and lung inflammation in vivo: molecular and cellular mechanisms. Br J Pharmacol 2015;172:1882-93. [PMID: 25439580 DOI: 10.1111/bph.13033] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
27 Chien PT, Hsieh HL, Chi PL, Yang CM. PAR1-dependent COX-2/PGE2 production contributes to cell proliferation via EP2 receptors in primary human cardiomyocytes. Br J Pharmacol 2014;171:4504-19. [PMID: 24902855 DOI: 10.1111/bph.12794] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
28 Lau BK, Drew GM, Mitchell VA, Vaughan CW. Endocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal grey. Br J Pharmacol 2014;171:5225-36. [PMID: 25041240 DOI: 10.1111/bph.12839] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
29 Cohen MV, Downey JM. Signalling pathways and mechanisms of protection in pre- and postconditioning: historical perspective and lessons for the future. Br J Pharmacol 2015;172:1913-32. [PMID: 25205071 DOI: 10.1111/bph.12903] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 8.8] [Reference Citation Analysis]
30 Cheishvili D, Boureau L, Szyf M. DNA demethylation and invasive cancer: implications for therapeutics. Br J Pharmacol 2015;172:2705-15. [PMID: 25134627 DOI: 10.1111/bph.12885] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 5.4] [Reference Citation Analysis]
31 Bosier B, Doyen PJ, Brolet A, Muccioli GG, Ahmed E, Desmet N, Hermans E, Deumens R. Inhibition of the regulator of G protein signalling RGS4 in the spinal cord decreases neuropathic hyperalgesia and restores cannabinoid CB1 receptor signalling. Br J Pharmacol 2015;172:5333-46. [PMID: 26478461 DOI: 10.1111/bph.13324] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
32 Bachelerie F, Graham GJ, Locati M, Mantovani A, Murphy PM, Nibbs R, Rot A, Sozzani S, Thelen M. An atypical addition to the chemokine receptor nomenclature: IUPHAR Review 15. Br J Pharmacol 2015;172:3945-9. [PMID: 25958743 DOI: 10.1111/bph.13182] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.9] [Reference Citation Analysis]
33 Pillidge K, Porter AJ, Dudley JA, Tsai YC, Heal DJ, Stanford SC. The behavioural response of mice lacking NK₁ receptors to guanfacine resembles its clinical profile in treatment of ADHD. Br J Pharmacol 2014;171:4785-96. [PMID: 25074741 DOI: 10.1111/bph.12860] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
34 Henderson G. The μ-opioid receptor: an electrophysiologist's perspective from the sharp end. Br J Pharmacol 2015;172:260-7. [PMID: 24640948 DOI: 10.1111/bph.12633] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
35 El-Daly M, Saifeddine M, Mihara K, Ramachandran R, Triggle CR, Hollenberg MD. Proteinase-activated receptors 1 and 2 and the regulation of porcine coronary artery contractility: a role for distinct tyrosine kinase pathways. Br J Pharmacol 2014;171:2413-25. [PMID: 24506284 DOI: 10.1111/bph.12593] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
36 Kojima A, Ito Y, Kitagawa H, Matsuura H. Ionic mechanisms underlying the negative chronotropic action of propofol on sinoatrial node automaticity in guinea pig heart. Br J Pharmacol 2015;172:799-814. [PMID: 25220338 DOI: 10.1111/bph.12936] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
37 Charfi I, Audet N, Bagheri Tudashki H, Pineyro G. Identifying ligand-specific signalling within biased responses: focus on δ opioid receptor ligands. Br J Pharmacol 2015;172:435-48. [PMID: 24665881 DOI: 10.1111/bph.12705] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
38 Alhosaini K, Azhar A, Alonazi A, Al-Zoghaibi F. GPCRs: The most promiscuous druggable receptor of the mankind. Saudi Pharm J 2021;29:539-51. [PMID: 34194261 DOI: 10.1016/j.jsps.2021.04.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Lindenbach D, Palumbo N, Ostock CY, Vilceus N, Conti MM, Bishop C. Side effect profile of 5-HT treatments for Parkinson's disease and L-DOPA-induced dyskinesia in rats. Br J Pharmacol 2015;172:119-30. [PMID: 25175895 DOI: 10.1111/bph.12894] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
40 Kazemi Z, Bergmayr C, Prchal-Murphy M, Javaheri T, Themanns M, Pham HT, Strohmaier W, Sexl V, Freissmuth M, Zebedin-Brandl E. Repurposing Treprostinil for Enhancing Hematopoietic Progenitor Cell Transplantation. Mol Pharmacol 2016;89:630-44. [PMID: 26989084 DOI: 10.1124/mol.116.103267] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
41 Meijerink J, Poland M, Balvers MG, Plastina P, Lute C, Dwarkasing J, van Norren K, Witkamp RF. Inhibition of COX-2-mediated eicosanoid production plays a major role in the anti-inflammatory effects of the endocannabinoid N-docosahexaenoylethanolamine (DHEA) in macrophages. Br J Pharmacol 2015;172:24-37. [PMID: 24780080 DOI: 10.1111/bph.12747] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
42 Reichelt AC, Westbrook RF, Morris MJ. Integration of reward signalling and appetite regulating peptide systems in the control of food-cue responses. Br J Pharmacol 2015;172:5225-38. [PMID: 26403657 DOI: 10.1111/bph.13321] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
43 Erdener SE, Dalkara T. Modelling headache and migraine and its pharmacological manipulation. Br J Pharmacol 2014;171:4575-94. [PMID: 24611635 DOI: 10.1111/bph.12651] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
44 Lowe AP, Thomas RS, Nials AT, Kidd EJ, Broadley KJ, Ford WR. LPS exacerbates functional and inflammatory responses to ovalbumin and decreases sensitivity to inhaled fluticasone propionate in a guinea pig model of asthma. Br J Pharmacol 2015;172:2588-603. [PMID: 25586266 DOI: 10.1111/bph.13080] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
45 Nozaki C, Nagase H, Nemoto T, Matifas A, Kieffer BL, Gaveriaux-Ruff C. In vivo properties of KNT-127, a novel δ opioid receptor agonist: receptor internalization, antihyperalgesia and antidepressant effects in mice. Br J Pharmacol 2014;171:5376-86. [PMID: 25048778 DOI: 10.1111/bph.12852] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
46 Suh HN, Han HJ. Sonic hedgehog increases the skin wound-healing ability of mouse embryonic stem cells through the microRNA 200 family. Br J Pharmacol 2015;172:815-28. [PMID: 25257936 DOI: 10.1111/bph.12947] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
47 Liberini CG, Boyle CN, Cifani C, Venniro M, Hope BT, Lutz TA, Watanabe M. Amylin receptor components and the leptin receptor are co-expressed in single rat area postrema neurons. Eur J Neurosci 2016;43:653-61. [DOI: 10.1111/ejn.13163] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 6.7] [Reference Citation Analysis]
48 Andradas C, Blasco-Benito S, Castillo-Lluva S, Dillenburg-Pilla P, Diez-Alarcia R, Juanes-García A, García-Taboada E, Hernando-Llorente R, Soriano J, Hamann S, Wenners A, Alkatout I, Klapper W, Rocken C, Bauer M, Arnold N, Quintanilla M, Megías D, Vicente-Manzanares M, Urigüen L, Gutkind JS, Guzmán M, Pérez-Gómez E, Sánchez C. Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer. Oncotarget 2016;7:47565-75. [PMID: 27340777 DOI: 10.18632/oncotarget.10206] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
49 Knapman A, Santiago M, Connor M. A6V polymorphism of the human μ-opioid receptor decreases signalling of morphine and endogenous opioids in vitro. Br J Pharmacol 2015;172:2258-72. [PMID: 25521224 DOI: 10.1111/bph.13047] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
50 Sengmany K, Gregory KJ. Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias. Br J Pharmacol 2016;173:3001-17. [PMID: 26276909 DOI: 10.1111/bph.13281] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
51 Pierre JF, Neuman JC, Brill AL, Brar HK, Thompson MF, Cadena MT, Connors KM, Busch RA, Heneghan AF, Cham CM, Jones EK, Kibbe CR, Davis DB, Groblewski GE, Kudsk KA, Kimple ME. The gastrin-releasing peptide analog bombesin preserves exocrine and endocrine pancreas morphology and function during parenteral nutrition. Am J Physiol Gastrointest Liver Physiol 2015;309:G431-42. [PMID: 26185331 DOI: 10.1152/ajpgi.00072.2015] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
52 Martin ED, Bassi R, Marber MS. p38 MAPK in cardioprotection - are we there yet? Br J Pharmacol 2015;172:2101-13. [PMID: 25204838 DOI: 10.1111/bph.12901] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 5.9] [Reference Citation Analysis]
53 Xu Y, Ma L, Jiang W, Li Y, Wang G, Li R. Study of Sex Differences in Duloxetine Efficacy for Depression in Transgenic Mouse Models. Front Cell Neurosci 2017;11:344. [PMID: 29163055 DOI: 10.3389/fncel.2017.00344] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
54 Gilchrist A, Gauntner TD, Fazzini A, Alley KM, Pyen DS, Ahn J, Ha SJ, Willett A, Sansom SE, Yarfi JL, Bachovchin KA, Mazzoni MR, Merritt JR. Identifying bias in CCR1 antagonists using radiolabelled binding, receptor internalization, β-arrestin translocation and chemotaxis assays. Br J Pharmacol 2014;171:5127-38. [PMID: 24990525 DOI: 10.1111/bph.12835] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
55 Walker CS, Sundrum T, Hay DL. PACAP receptor pharmacology and agonist bias: analysis in primary neurons and glia from the trigeminal ganglia and transfected cells. Br J Pharmacol 2014;171:1521-33. [PMID: 24303997 DOI: 10.1111/bph.12541] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
56 Arttamangkul S, Birdsong W, Williams JT. Does PKC activation increase the homologous desensitization of μ opioid receptors? Br J Pharmacol 2015;172:583-92. [PMID: 24697621 DOI: 10.1111/bph.12712] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
57 Cruz-Barbosa R, Vellido A, Giraldo J. The influence of alignment-free sequence representations on the semi-supervised classification of class C G protein-coupled receptors: semi-supervised classification of class C GPCRs. Med Biol Eng Comput 2015;53:137-49. [PMID: 25367737 DOI: 10.1007/s11517-014-1218-y] [Cited by in Crossref: 9] [Article Influence: 1.1] [Reference Citation Analysis]
58 Taffe MA, Creehan KM, Vandewater SA. Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats. Br J Pharmacol 2015;172:1783-91. [PMID: 25425111 DOI: 10.1111/bph.13024] [Cited by in Crossref: 50] [Cited by in F6Publishing: 37] [Article Influence: 7.1] [Reference Citation Analysis]
59 Condés-lara M, Martínez-lorenzana G, Rubio-beltrán E, Rodríguez-jiménez J, Rojas-piloni G, González-hernández A. Hypothalamic paraventricular nucleus stimulation enhances c-Fos expression in spinal and supraspinal structures related to pain modulation. Neuroscience Research 2015;98:59-63. [DOI: 10.1016/j.neures.2015.04.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
60 Lieu T, Jayaweera G, Bunnett NW. GPBA: a GPCR for bile acids and an emerging therapeutic target for disorders of digestion and sensation. Br J Pharmacol. 2014;171:1156-1166. [PMID: 24111923 DOI: 10.1111/bph.12426] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 4.4] [Reference Citation Analysis]
61 Wifling D, Löffel K, Nordemann U, Strasser A, Bernhardt G, Dove S, Seifert R, Buschauer A. Molecular determinants for the high constitutive activity of the human histamine H4 receptor: functional studies on orthologues and mutants. Br J Pharmacol 2015;172:785-98. [PMID: 24903527 DOI: 10.1111/bph.12801] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
62 Burford NT, Traynor JR, Alt A. Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications. Br J Pharmacol 2015;172:277-86. [PMID: 24460691 DOI: 10.1111/bph.12599] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 5.9] [Reference Citation Analysis]
63 Xu W, Dahlke SP, Emery AC, Sung M, Chepurny OG, Holz GG, Eiden LE. Cyclic AMP-dependent activation of ERK via GLP-1 receptor signalling requires the neuroendocrine cell-specific guanine nucleotide exchanger NCS-RapGEF2. J Neuroendocrinol 2021;33:e12974. [PMID: 33960038 DOI: 10.1111/jne.12974] [Reference Citation Analysis]
64 Illing S, Mann A, Schulz S. Heterologous regulation of agonist-independent μ-opioid receptor phosphorylation by protein kinase C. Br J Pharmacol 2014;171:1330-40. [PMID: 24308893 DOI: 10.1111/bph.12546] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
65 Bukalo O, Pinard CR, Holmes A. Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders. Br J Pharmacol 2014;171:4690-718. [PMID: 24835117 DOI: 10.1111/bph.12779] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.8] [Reference Citation Analysis]
66 Duthie KM, Hadoke PW, Kirkby NS, Miller E, Ivy JR, McShane JF, Lim WG, Webb DJ. Selective endothelin A receptor antagonism with sitaxentan reduces neointimal lesion size in a mouse model of intraluminal injury. Br J Pharmacol 2015;172:2827-37. [PMID: 25598351 DOI: 10.1111/bph.13086] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
67 Milligan G, Shimpukade B, Ulven T, Hudson BD. Complex Pharmacology of Free Fatty Acid Receptors. Chem Rev 2017;117:67-110. [PMID: 27299848 DOI: 10.1021/acs.chemrev.6b00056] [Cited by in Crossref: 117] [Cited by in F6Publishing: 109] [Article Influence: 19.5] [Reference Citation Analysis]
68 Triguero D, Lafuente-Sanchis A, Garcia-Pascual A. Changes in nerve-mediated contractility of the lower urinary tract in a mouse model of premature ageing. Br J Pharmacol 2014;171:1687-705. [PMID: 24372152 DOI: 10.1111/bph.12567] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
69 Connor M, Bagley EE, Chieng BC, Christie MJ. β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons. Br J Pharmacol 2015;172:492-500. [PMID: 24597632 DOI: 10.1111/bph.12673] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
70 Lozić M, Greenwood M, Šarenac O, Martin A, Hindmarch C, Tasić T, Paton J, Murphy D, Japundžić-Žigon N. Overexpression of oxytocin receptors in the hypothalamic PVN increases baroreceptor reflex sensitivity and buffers BP variability in conscious rats. Br J Pharmacol 2014;171:4385-98. [PMID: 24834854 DOI: 10.1111/bph.12776] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
71 Birrell MA, Bonvini SJ, Wortley MA, Buckley J, Yew-Booth L, Maher SA, Dale N, Dubuis ED, Belvisi MG. The role of adenylyl cyclase isoform 6 in β-adrenoceptor signalling in murine airways. Br J Pharmacol 2015;172:131-41. [PMID: 25205328 DOI: 10.1111/bph.12905] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
72 Schuchard J, Winkler M, Stölting I, Schuster F, Vogt FM, Barkhausen J, Thorns C, Santos RA, Bader M, Raasch W. Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)/Mas-dependent pathway. Br J Pharmacol 2015;172:3764-78. [PMID: 25906670 DOI: 10.1111/bph.13172] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
73 Hill SJ, May LT, Kellam B, Woolard J. Allosteric interactions at adenosine A(1) and A(3) receptors: new insights into the role of small molecules and receptor dimerization. Br J Pharmacol 2014;171:1102-13. [PMID: 24024783 DOI: 10.1111/bph.12345] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 5.5] [Reference Citation Analysis]
74 Yu Z, IJzerman AP, Heitman LH. Kv 11.1 (hERG)-induced cardiotoxicity: a molecular insight from a binding kinetics study of prototypical Kv 11.1 (hERG) inhibitors. Br J Pharmacol 2015;172:940-55. [PMID: 25296617 DOI: 10.1111/bph.12967] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
75 Taylor GT, Manzella F. Kappa Opioids, Salvinorin A and Major Depressive Disorder. Curr Neuropharmacol 2016;14:165-76. [PMID: 26903446 DOI: 10.2174/1570159x13666150727220944] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
76 Arai K, Kashiwazaki A, Fujiwara Y, Tsuchiya H, Sakai N, Shibata K, Koshimizu TA. Pharmacological lineage analysis revealed the binding affinity of broad-spectrum substance P antagonists to receptors for gonadotropin-releasing peptide. Eur J Pharmacol 2015;749:98-106. [PMID: 25592317 DOI: 10.1016/j.ejphar.2015.01.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
77 Oxombre B, Lee-Chang C, Duhamel A, Toussaint M, Giroux M, Donnier-Maréchal M, Carato P, Lefranc D, Zéphir H, Prin L, Melnyk P, Vermersch P. High-affinity σ1 protein agonist reduces clinical and pathological signs of experimental autoimmune encephalomyelitis. Br J Pharmacol 2015;172:1769-82. [PMID: 25521311 DOI: 10.1111/bph.13037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
78 Rickli A, Kopf S, Hoener MC, Liechti ME. Pharmacological profile of novel psychoactive benzofurans. Br J Pharmacol 2015;172:3412-25. [PMID: 25765500 DOI: 10.1111/bph.13128] [Cited by in Crossref: 75] [Cited by in F6Publishing: 64] [Article Influence: 10.7] [Reference Citation Analysis]
79 Yadav VR, Nayeem MA, Tilley SL, Mustafa SJ. Angiotensin II stimulation alters vasomotor response to adenosine in mouse mesenteric artery: role for A1 and A2B adenosine receptors. Br J Pharmacol 2015;172:4959-69. [PMID: 26227882 DOI: 10.1111/bph.13265] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
80 Harada K, Matsuoka H, Miyata H, Matsui M, Inoue M. Identification of muscarinic receptor subtypes involved in catecholamine secretion in adrenal medullary chromaffin cells by genetic deletion. Br J Pharmacol 2015;172:1348-59. [PMID: 25393049 DOI: 10.1111/bph.13011] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
81 Chin KY, Qin C, Cao N, Kemp-Harper BK, Woodman OL, Ritchie RH. The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms. Br J Pharmacol 2014;171:1722-34. [PMID: 24372173 DOI: 10.1111/bph.12568] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
82 Knapman A, Santiago M, Connor M. Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitro. Br J Pharmacol 2014;171:4273-88. [PMID: 24846673 DOI: 10.1111/bph.12785] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
83 Kaneko H, Ye F, Ijima R, Kachi S, Kato S, Nagaya M, Higuchi A, Terasaki H. Histamine H4 receptor as a new therapeutic target for choroidal neovascularization in age-related macular degeneration. Br J Pharmacol 2014;171:3754-63. [PMID: 24787705 DOI: 10.1111/bph.12737] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
84 Kasutani K, Fujii E, Ohyama S, Adachi H, Hasegawa M, Kitamura H, Yamashita N. Anti-IL-31 receptor antibody is shown to be a potential therapeutic option for treating itch and dermatitis in mice. Br J Pharmacol 2014;171:5049-58. [PMID: 24946165 DOI: 10.1111/bph.12823] [Cited by in Crossref: 14] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
85 Ichikawa J, Inoue R. TRPC6 regulates cell cycle progression by modulating membrane potential in bone marrow stromal cells. Br J Pharmacol 2014;171:5280-94. [PMID: 25041367 DOI: 10.1111/bph.12840] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
86 Poppinga WJ, Muñoz-Llancao P, González-Billault C, Schmidt M. A-kinase anchoring proteins: cAMP compartmentalization in neurodegenerative and obstructive pulmonary diseases. Br J Pharmacol 2014;171:5603-23. [PMID: 25132049 DOI: 10.1111/bph.12882] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
87 Peixoto-Neves D, Wang Q, Leal-Cardoso JH, Rossoni LV, Jaggar JH. Eugenol dilates mesenteric arteries and reduces systemic BP by activating endothelial cell TRPV4 channels. Br J Pharmacol 2015;172:3484-94. [PMID: 25832173 DOI: 10.1111/bph.13156] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
88 Conibear AE, Kelly E. A Biased View of μ-Opioid Receptors? Mol Pharmacol 2019;96:542-9. [PMID: 31175184 DOI: 10.1124/mol.119.115956] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 18.0] [Reference Citation Analysis]
89 Salaga M, Polepally PR, Zielinska M, Marynowski M, Fabisiak A, Murawska N, Sobczak K, Sacharczuk M, Do Rego JC, Roth BL, Zjawiony JK, Fichna J. Salvinorin A analogues PR-37 and PR-38 attenuate compound 48/80-induced itch responses in mice. Br J Pharmacol 2015;172:4331-41. [PMID: 26040667 DOI: 10.1111/bph.13212] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
90 Gros F, Muller S. Pharmacological regulators of autophagy and their link with modulators of lupus disease. Br J Pharmacol 2014;171:4337-59. [PMID: 24902607 DOI: 10.1111/bph.12792] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
91 Sadeghi M, Tzschentke TM, Christie MJ. μ-Opioid receptor activation and noradrenaline transport inhibition by tapentadol in rat single locus coeruleus neurons. Br J Pharmacol 2015;172:460-8. [PMID: 24372103 DOI: 10.1111/bph.12566] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
92 Thiele S, Mungalpara J, Steen A, Rosenkilde MM, Våbenø J. Determination of the binding mode for the cyclopentapeptide CXCR4 antagonist FC131 using a dual approach of ligand modifications and receptor mutagenesis. Br J Pharmacol 2014;171:5313-29. [PMID: 25039237 DOI: 10.1111/bph.12842] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 4.3] [Reference Citation Analysis]
93 Read MI, Harrison JC, Kerr DS, Sammut IA. Atenolol offers better protection than clonidine against cardiac injury in kainic acid-induced status epilepticus. Br J Pharmacol 2015;172:4626-38. [PMID: 25765931 DOI: 10.1111/bph.13132] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
94 Papapetropoulos A, Hobbs AJ, Topouzis S. Extending the translational potential of targeting NO/cGMP-regulated pathways in the CVS. Br J Pharmacol 2015;172:1397-414. [PMID: 25302549 DOI: 10.1111/bph.12980] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
95 Hollenberg MD. Proteinases, their receptors and inflammatory signalling: the Oxford South Parks Road connection. Br J Pharmacol 2015;172:3196-211. [PMID: 25521749 DOI: 10.1111/bph.13041] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
96 Perry CJ, Zbukvic I, Kim JH, Lawrence AJ. Role of cues and contexts on drug-seeking behaviour. Br J Pharmacol 2014;171:4636-72. [PMID: 24749941 DOI: 10.1111/bph.12735] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 7.1] [Reference Citation Analysis]
97 Hoyer D, Jacobson LH. Orexin Receptor Antagonists. Curr Sleep Medicine Rep 2017;3:342-53. [DOI: 10.1007/s40675-017-0099-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
98 Meneguetti BT, Cardoso MH, Ribeiro CF, Felício MR, Pinto IB, Santos NC, Carvalho CM, Franco OL. Neuropeptide receptors as potential pharmacological targets for obesity. Pharmacology & Therapeutics 2019;196:59-78. [DOI: 10.1016/j.pharmthera.2018.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
99 Fernandez-Gonzalez P, Mas-Sanchez A, Garriga P. Polyphenols and Visual Health: Potential Effects on Degenerative Retinal Diseases. Molecules 2021;26:3407. [PMID: 34199888 DOI: 10.3390/molecules26113407] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Lodge D, Mercier MS. Ketamine and phencyclidine: the good, the bad and the unexpected. Br J Pharmacol 2015;172:4254-76. [PMID: 26075331 DOI: 10.1111/bph.13222] [Cited by in Crossref: 105] [Cited by in F6Publishing: 88] [Article Influence: 15.0] [Reference Citation Analysis]
101 Ramachandran R, Yaksh TL. Therapeutic use of botulinum toxin in migraine: mechanisms of action. Br J Pharmacol 2014;171:4177-92. [PMID: 24819339 DOI: 10.1111/bph.12763] [Cited by in Crossref: 57] [Cited by in F6Publishing: 45] [Article Influence: 8.1] [Reference Citation Analysis]
102 Calvo DJ, Beltrán González AN. Dynamic Regulation of the GABAA Receptor Function by Redox Mechanisms. Mol Pharmacol 2016;90:326-33. [PMID: 27439531 DOI: 10.1124/mol.116.105205] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
103 Hind WH, Tufarelli C, Neophytou M, Anderson SI, England TJ, O'Sullivan SE. Endocannabinoids modulate human blood-brain barrier permeability in vitro. Br J Pharmacol 2015;172:3015-27. [PMID: 25651941 DOI: 10.1111/bph.13106] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 7.9] [Reference Citation Analysis]
104 Godinho RO, Duarte T, Pacini ES. New perspectives in signaling mediated by receptors coupled to stimulatory G protein: the emerging significance of cAMP efflux and extracellular cAMP-adenosine pathway. Front Pharmacol 2015;6:58. [PMID: 25859216 DOI: 10.3389/fphar.2015.00058] [Cited by in Crossref: 49] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
105 Todd SM, Arnold JC. Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis. Br J Pharmacol 2016;173:53-65. [PMID: 26377899 DOI: 10.1111/bph.13333] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 6.9] [Reference Citation Analysis]
106 Rizzi A, Malfacini D, Cerlesi MC, Ruzza C, Marzola E, Bird MF, Rowbotham DJ, Salvadori S, Guerrini R, Lambert DG, Calo G. In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives. Br J Pharmacol 2014;171:4138-53. [PMID: 24903280 DOI: 10.1111/bph.12799] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
107 Silva RB, Sperotto ND, Andrade EL, Pereira TC, Leite CE, de Souza AH, Bogo MR, Morrone FB, Gomez MV, Campos MM. Spinal blockage of P/Q- or N-type voltage-gated calcium channels modulates functional and symptomatic changes related to haemorrhagic cystitis in mice. Br J Pharmacol 2015;172:924-39. [PMID: 25298144 DOI: 10.1111/bph.12966] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
108 Saifeddine M, El-Daly M, Mihara K, Bunnett NW, McIntyre P, Altier C, Hollenberg MD, Ramachandran R. GPCR-mediated EGF receptor transactivation regulates TRPV4 action in the vasculature. Br J Pharmacol 2015;172:2493-506. [PMID: 25572823 DOI: 10.1111/bph.13072] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
109 Malfacini D, Ambrosio C, Gro' MC, Sbraccia M, Trapella C, Guerrini R, Bonora M, Pinton P, Costa T, Calo' G. Pharmacological Profile of Nociceptin/Orphanin FQ Receptors Interacting with G-Proteins and β-Arrestins 2. PLoS One 2015;10:e0132865. [PMID: 26248189 DOI: 10.1371/journal.pone.0132865] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.7] [Reference Citation Analysis]
110 Aldrich JV, Senadheera SN, Ross NC, Reilley KA, Ganno ML, Eans SE, Murray TF, McLaughlin JP. Alanine analogues of [D-Trp]CJ-15,208: novel opioid activity profiles and prevention of drug- and stress-induced reinstatement of cocaine-seeking behaviour. Br J Pharmacol 2014;171:3212-22. [PMID: 24588614 DOI: 10.1111/bph.12664] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
111 Maroteaux L, Kilic F. Frontiers of Serotonin Beyond the Brain. Pharmacol Res 2019;140:1-6. [PMID: 30359688 DOI: 10.1016/j.phrs.2018.10.022] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
112 Hicks C, Ramos L, Reekie T, Misagh GH, Narlawar R, Kassiou M, McGregor IS. Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats. Br J Pharmacol 2014;171:2868-87. [PMID: 24641248 DOI: 10.1111/bph.12613] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 6.8] [Reference Citation Analysis]
113 Di Prisco S, Merega E, Lanfranco M, Casazza S, Uccelli A, Pittaluga A. Acute desipramine restores presynaptic cortical defects in murine experimental autoimmune encephalomyelitis by suppressing central CCL5 overproduction. Br J Pharmacol 2014;171:2457-67. [PMID: 24528439 DOI: 10.1111/bph.12631] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
114 Fan H, Gong N, Li TF, Ma AN, Wu XY, Wang MW, Wang YX. The non-peptide GLP-1 receptor agonist WB4-24 blocks inflammatory nociception by stimulating β-endorphin release from spinal microglia. Br J Pharmacol 2015;172:64-79. [PMID: 25176008 DOI: 10.1111/bph.12895] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
115 Hollenberg MD, Mihara K, Polley D, Suen JY, Han A, Fairlie DP, Ramachandran R. Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease. Br J Pharmacol 2014;171:1180-94. [PMID: 24354792 DOI: 10.1111/bph.12544] [Cited by in Crossref: 117] [Cited by in F6Publishing: 104] [Article Influence: 14.6] [Reference Citation Analysis]
116 Kenakin T. Gaddum Memorial Lecture 2014: receptors as an evolving concept: from switches to biased microprocessors. Br J Pharmacol 2015;172:4238-53. [PMID: 26075971 DOI: 10.1111/bph.13217] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
117 Macías A, de la Cruz A, Prieto A, Peraza DA, Tamkun MM, González T, Valenzuela C. PKC inhibition results in a Kv 1.5 + Kv β1.3 pharmacology closer to Kv 1.5 channels. Br J Pharmacol 2014;171:4914-26. [PMID: 24946104 DOI: 10.1111/bph.12822] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
118 Grassin-Delyle S, Naline E, Buenestado A, Faisy C, Alvarez JC, Salvator H, Abrial C, Advenier C, Zemoura L, Devillier P. Cannabinoids inhibit cholinergic contraction in human airways through prejunctional CB1 receptors. Br J Pharmacol 2014;171:2767-77. [PMID: 24467410 DOI: 10.1111/bph.12597] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
119 Bice JS, Baxter GF. Postconditioning signalling in the heart: mechanisms and translatability. Br J Pharmacol 2015;172:1933-46. [PMID: 25303373 DOI: 10.1111/bph.12976] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
120 Sarwar M, Samuel CS, Bathgate RA, Stewart DR, Summers RJ. Enhanced serelaxin signalling in co-cultures of human primary endothelial and smooth muscle cells. Br J Pharmacol 2016;173:484-96. [PMID: 26493539 DOI: 10.1111/bph.13371] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
121 Kowalski M, Hausmann R, Dopychai A, Grohmann M, Franke H, Nieber K, Schmalzing G, Illes P, Riedel T. Conformational flexibility of the agonist binding jaw of the human P2X3 receptor is a prerequisite for channel opening. Br J Pharmacol 2014;171:5093-112. [PMID: 24989924 DOI: 10.1111/bph.12830] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 0.5] [Reference Citation Analysis]
122 Edvinsson L. PACAP and its receptors in migraine pathophysiology: Commentary on Walker et al., Br J Pharmacol 171: 1521-1533. Br J Pharmacol 2015;172:4782-4. [PMID: 24826981 DOI: 10.1111/bph.12772] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
123 Jiang T, Yu JT, Zhu XC, Zhang QQ, Tan MS, Cao L, Wang HF, Lu J, Gao Q, Zhang YD, Tan L. Angiotensin-(1-7) induces cerebral ischaemic tolerance by promoting brain angiogenesis in a Mas/eNOS-dependent pathway. Br J Pharmacol 2014;171:4222-32. [PMID: 24824997 DOI: 10.1111/bph.12770] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 6.9] [Reference Citation Analysis]
124 van Gestel MA, Kostrzewa E, Adan RA, Janhunen SK. Pharmacological manipulations in animal models of anorexia and binge eating in relation to humans. Br J Pharmacol 2014;171:4767-84. [PMID: 24866852 DOI: 10.1111/bph.12789] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
125 Takasu K, Ogawa K, Nakamura A, Kanbara T, Ono H, Tomii T, Morioka Y, Hasegawa M, Shibasaki M, Mori T, Suzuki T, Sakaguchi G. Enhanced GABAergic synaptic transmission at VLPAG neurons and potent modulation by oxycodone in a bone cancer pain model. Br J Pharmacol 2015;172:2148-64. [PMID: 25521524 DOI: 10.1111/bph.13039] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
126 Muldoon PP, Chen J, Harenza JL, Abdullah RA, Sim-Selley LJ, Cravatt BF, Miles MF, Chen X, Lichtman AH, Damaj MI. Inhibition of monoacylglycerol lipase reduces nicotine withdrawal. Br J Pharmacol 2015;172:869-82. [PMID: 25258021 DOI: 10.1111/bph.12948] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
127 McPartland JM, Duncan M, Di Marzo V, Pertwee RG. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. Br J Pharmacol 2015;172:737-53. [PMID: 25257544 DOI: 10.1111/bph.12944] [Cited by in Crossref: 283] [Cited by in F6Publishing: 257] [Article Influence: 40.4] [Reference Citation Analysis]
128 Bohan R, Tianyu X, Tiantian Z, Ruonan F, Hongtao H, Qiong W, Chao S. Gut microbiota: a potential manipulator for host adipose tissue and energy metabolism. The Journal of Nutritional Biochemistry 2019;64:206-17. [DOI: 10.1016/j.jnutbio.2018.10.020] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
129 Khroyan TV, Wu J, Polgar WE, Cami-Kobeci G, Fotaki N, Husbands SM, Toll L. BU08073 a buprenorphine analogue with partial agonist activity at μ-receptors in vitro but long-lasting opioid antagonist activity in vivo in mice. Br J Pharmacol 2015;172:668-80. [PMID: 24903063 DOI: 10.1111/bph.12796] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
130 Liu HM, Ma LL, Li C, Cao B, Jiang Y, Han L, Xu R, Lin J, Zhang D. The molecular mechanism of chronic stress affecting the occurrence and development of breast cancer and potential drug therapy. Transl Oncol 2022;15:101281. [PMID: 34875482 DOI: 10.1016/j.tranon.2021.101281] [Reference Citation Analysis]
131 Cottingham C, Ferryman CJ, Wang Q. α2 Adrenergic Receptor Trafficking as a Therapeutic Target in Antidepressant Drug Action. Trafficking of GPCRs. Elsevier; 2015. pp. 207-25. [DOI: 10.1016/bs.pmbts.2015.03.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
132 Macey TA, Bobeck EN, Suchland KL, Morgan MM, Ingram SL. Change in functional selectivity of morphine with the development of antinociceptive tolerance. Br J Pharmacol 2015;172:549-61. [PMID: 24666417 DOI: 10.1111/bph.12703] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
133 Ciudad-Roberts A, Camarasa J, Ciudad CJ, Pubill D, Escubedo E. Alcohol enhances the psychostimulant and conditioning effects of mephedrone in adolescent mice; postulation of unique roles of D3 receptors and BDNF in place preference acquisition. Br J Pharmacol 2015;172:4970-84. [PMID: 26228024 DOI: 10.1111/bph.13266] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
134 Laurent V, Morse AK, Balleine BW. The role of opioid processes in reward and decision-making. Br J Pharmacol 2015;172:449-59. [PMID: 24930675 DOI: 10.1111/bph.12818] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
135 Gupta A, Fujita W, Gomes I, Bobeck E, Devi LA. Endothelin-converting enzyme 2 differentially regulates opioid receptor activity. Br J Pharmacol 2015;172:704-19. [PMID: 24990314 DOI: 10.1111/bph.12833] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
136 Takatori S, Hirai K, Ozaki S, Tangsucharit P, Fukushima-Miyashita S, Goda M, Hashikawa-Hobara N, Ono N, Kawasaki H. Protons modulate perivascular axo-axonal neurotransmission in the rat mesenteric artery. Br J Pharmacol 2014;171:5743-56. [PMID: 25117291 DOI: 10.1111/bph.12878] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
137 Liberini CG, Borner T, Boyle CN, Lutz TA. The satiating hormone amylin enhances neurogenesis in the area postrema of adult rats. Mol Metab 2016;5:834-43. [PMID: 27688997 DOI: 10.1016/j.molmet.2016.06.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
138 Ha H, Bensman T, Ho H, Beringer PM, Neamati N. A novel phenylcyclohex-1-enecarbothioamide derivative inhibits CXCL8-mediated chemotaxis through selective regulation of CXCR2-mediated signalling. Br J Pharmacol 2014;171:1551-65. [PMID: 24354854 DOI: 10.1111/bph.12547] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
139 Grace MS, Lieu T, Darby B, Abogadie FC, Veldhuis N, Bunnett NW, McIntyre P. The tyrosine kinase inhibitor bafetinib inhibits PAR2-induced activation of TRPV4 channels in vitro and pain in vivo. Br J Pharmacol 2014;171:3881-94. [PMID: 24779362 DOI: 10.1111/bph.12750] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 4.7] [Reference Citation Analysis]
140 Stewart AG, Beart PM. Inflammation: maladies, models, mechanisms and molecules. Br J Pharmacol 2016;173:631-4. [PMID: 26847725 DOI: 10.1111/bph.13389] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
141 Kao JH, Gao MJ, Yang PP, Law PY, Loh HH, Tao PL. Effect of naltrexone on neuropathic pain in mice locally transfected with the mutant μ-opioid receptor gene in spinal cord. Br J Pharmacol 2015;172:630-41. [PMID: 24866991 DOI: 10.1111/bph.12790] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
142 Nedjai B, Viney JM, Li H, Hull C, Anderson CA, Horie T, Horuk R, Vaidehi N, Pease JE. CXCR3 antagonist VUF10085 binds to an intrahelical site distinct from that of the broad spectrum antagonist TAK-779. Br J Pharmacol 2015;172:1822-33. [PMID: 25425280 DOI: 10.1111/bph.13027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
143 Hay DL, Chen S, Lutz TA, Parkes DG, Roth JD. Amylin: Pharmacology, Physiology, and Clinical Potential. Pharmacol Rev 2015;67:564-600. [PMID: 26071095 DOI: 10.1124/pr.115.010629] [Cited by in Crossref: 176] [Cited by in F6Publishing: 156] [Article Influence: 29.3] [Reference Citation Analysis]
144 Tasma Z, Wills P, Hay DL, Walker CS. Agonist bias and agonist-dependent antagonism at corticotrophin releasing factor receptors. Pharmacol Res Perspect 2020;8:e00595. [PMID: 32529807 DOI: 10.1002/prp2.595] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Kalinichev M, Donovan-Rodriguez T, Girard F, Riguet E, Rouillier M, Bournique B, Haddouk H, Mutel V, Poli S. Evaluation of peripheral versus central effects of GABA(B) receptor activation using a novel, positive allosteric modulator of the GABA(B) receptor ADX71943, a pharmacological tool compound with a fully peripheral activity profile. Br J Pharmacol 2014;171:4941-54. [PMID: 24923436 DOI: 10.1111/bph.12812] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
146 Adewumi AD, Staatz CE, Hollingworth SA, Connor JP, Alati R. Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit. Drug Saf 2018;41:1023-33. [DOI: 10.1007/s40264-018-0687-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
147 Omori K, Kida T, Hori M, Ozaki H, Murata T. Multiple roles of the PGE2 -EP receptor signal in vascular permeability. Br J Pharmacol 2014;171:4879-89. [PMID: 24923772 DOI: 10.1111/bph.12815] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
148 Gavriatopoulou M, Dimopoulos MA, Kastritis E, Terpos E. Emerging treatment approaches for myeloma-related bone disease. Expert Rev Hematol 2017;10:217-28. [PMID: 28092987 DOI: 10.1080/17474086.2017.1283213] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
149 Vasconcelos LHC, Silva MDCC, Costa AC, de Oliveira GA, de Souza ILL, Queiroga FR, Araujo LCDC, Cardoso GA, Righetti RF, Silva AS, da Silva PM, Carvalho CRO, Vieira GC, Tibério IFLC, Cavalcante FA, da Silva BA. A Guinea Pig Model of Airway Smooth Muscle Hyperreactivity Induced by Chronic Allergic Lung Inflammation: Contribution of Epithelium and Oxidative Stress. Front Pharmacol 2018;9:1547. [PMID: 30814952 DOI: 10.3389/fphar.2018.01547] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
150 Bigliardi PL, Neumann C, Teo YL, Pant A, Bigliardi-Qi M. Activation of the δ-opioid receptor promotes cutaneous wound healing by affecting keratinocyte intercellular adhesion and migration. Br J Pharmacol 2015;172:501-14. [PMID: 24628261 DOI: 10.1111/bph.12687] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
151 Escudero P, Navarro A, Ferrando C, Furio E, Gonzalez-Navarro H, Juez M, Sanz MJ, Piqueras L. Combined treatment with bexarotene and rosuvastatin reduces angiotensin-II-induced abdominal aortic aneurysm in apoE(-/-) mice and angiogenesis. Br J Pharmacol 2015;172:2946-60. [PMID: 25630951 DOI: 10.1111/bph.13098] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
152 Ahmad R, Wojciech S, Jockers R. Hunting for the function of orphan GPCRs - beyond the search for the endogenous ligand. Br J Pharmacol 2015;172:3212-28. [PMID: 25231237 DOI: 10.1111/bph.12942] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
153 Shukeir N, Stefanska B, Parashar S, Chik F, Arakelian A, Szyf M, Rabbani SA. Pharmacological methyl group donors block skeletal metastasis in vitro and in vivo. Br J Pharmacol 2015;172:2769-81. [PMID: 25631332 DOI: 10.1111/bph.13102] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
154 Engelstoft MS, Norn C, Hauge M, Holliday ND, Elster L, Lehmann J, Jones RM, Frimurer TM, Schwartz TW. Structural basis for constitutive activity and agonist-induced activation of the enteroendocrine fat sensor GPR119. Br J Pharmacol 2014;171:5774-89. [PMID: 25117266 DOI: 10.1111/bph.12877] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
155 Schrage R, De Min A, Hochheiser K, Kostenis E, Mohr K. Superagonism at G protein-coupled receptors and beyond. Br J Pharmacol 2016;173:3018-27. [PMID: 26276510 DOI: 10.1111/bph.13278] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
156 de Queiroz DB, Sastre E, Caracuel L, Callejo M, Xavier FE, Blanco-Rivero J, Balfagón G. Alterations in perivascular innervation function in mesenteric arteries from offspring of diabetic rats. Br J Pharmacol 2015;172:4699-713. [PMID: 26177571 DOI: 10.1111/bph.13244] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
157 Lowe JD, Bailey CP. Functional selectivity and time-dependence of μ-opioid receptor desensitization at nerve terminals in the mouse ventral tegmental area. Br J Pharmacol 2015;172:469-81. [PMID: 24467517 DOI: 10.1111/bph.12605] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
158 Schuster DJ, Metcalf MD, Kitto KF, Messing RO, Fairbanks CA, Wilcox GL. Ligand requirements for involvement of PKCε in synergistic analgesic interactions between spinal μ and δ opioid receptors. Br J Pharmacol 2015;172:642-53. [PMID: 24827408 DOI: 10.1111/bph.12774] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
159 Hubert F, Belacel-Ouari M, Manoury B, Zhai K, Domergue-Dupont V, Mateo P, Joubert F, Fischmeister R, Leblais V. Alteration of vascular reactivity in heart failure: role of phosphodiesterases 3 and 4. Br J Pharmacol 2014;171:5361-75. [PMID: 25048877 DOI: 10.1111/bph.12853] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
160 Malvar Ddo C, Aguiar FA, Vaz Ade L, Assis DC, de Melo MC, Jabor VA, Kalapothakis E, Ferreira SH, Clososki GC, de Souza GE. Dipyrone metabolite 4-MAA induces hypothermia and inhibits PGE2 -dependent and -independent fever while 4-AA only blocks PGE2 -dependent fever. Br J Pharmacol 2014;171:3666-79. [PMID: 24712707 DOI: 10.1111/bph.12717] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
161 Fife CM, McCarroll JA, Kavallaris M. Movers and shakers: cell cytoskeleton in cancer metastasis. Br J Pharmacol 2014;171:5507-23. [PMID: 24665826 DOI: 10.1111/bph.12704] [Cited by in Crossref: 259] [Cited by in F6Publishing: 243] [Article Influence: 32.4] [Reference Citation Analysis]
162 Tiligada E, Ishii M, Riccardi C, Spedding M, Simon HU, Teixeira MM, Cuervo ML, Holgate ST, Levi-Schaffer F. The expanding role of immunopharmacology: IUPHAR Review 16. Br J Pharmacol 2015;172:4217-27. [PMID: 26173913 DOI: 10.1111/bph.13219] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
163 Woo AY, Song Y, Zhu W, Xiao RP. Advances in receptor conformation research: the quest for functionally selective conformations focusing on the β2-adrenoceptor. Br J Pharmacol 2015;172:5477-88. [PMID: 25537131 DOI: 10.1111/bph.13049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
164 Zhang X, Feng ZJ, Chergui K. Allosteric modulation of GluN2C/GluN2D-containing NMDA receptors bidirectionally modulates dopamine release: implication for Parkinson's disease. Br J Pharmacol 2014;171:3938-45. [PMID: 24818560 DOI: 10.1111/bph.12758] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
165 Müller-Fielitz H, Lau M, Geißler C, Werner L, Winkler M, Raasch W. Preventing leptin resistance by blocking angiotensin II AT1 receptors in diet-induced obese rats. Br J Pharmacol 2015;172:857-68. [PMID: 25258168 DOI: 10.1111/bph.12949] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
166 Taschler U, Eichmann TO, Radner FP, Grabner GF, Wolinski H, Storr M, Lass A, Schicho R, Zimmermann R. Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity. Br J Pharmacol 2015;172:4419-29. [PMID: 26075589 DOI: 10.1111/bph.13224] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
167 Kikuchi C, Dosenovic S, Bienengraeber M. Anaesthetics as cardioprotectants: translatability and mechanism. Br J Pharmacol. 2015;172:2051-2061. [PMID: 25322898 DOI: 10.1111/bph.2015.172.issue-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
168 Tallis J, Duncan MJ, James RS. What can isolated skeletal muscle experiments tell us about the effects of caffeine on exercise performance? Br J Pharmacol 2015;172:3703-13. [PMID: 25988508 DOI: 10.1111/bph.13187] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 6.4] [Reference Citation Analysis]
169 Godar SC, Mosher LJ, Strathman HJ, Gochi AM, Jones CM, Fowler SC, Bortolato M. The D1CT-7 mouse model of Tourette syndrome displays sensorimotor gating deficits in response to spatial confinement. Br J Pharmacol 2016;173:2111-21. [PMID: 26171666 DOI: 10.1111/bph.13243] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
170 Guardiola-Lemaitre B, De Bodinat C, Delagrange P, Millan MJ, Munoz C, Mocaër E. Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties. Br J Pharmacol 2014;171:3604-19. [PMID: 24724693 DOI: 10.1111/bph.12720] [Cited by in Crossref: 86] [Cited by in F6Publishing: 76] [Article Influence: 14.3] [Reference Citation Analysis]
171 Isensee J, Krahé L, Moeller K, Pereira V, Sexton JE, Sun X, Emery E, Wood JN, Hucho T. Synergistic regulation of serotonin and opioid signaling contributes to pain insensitivity in Nav1.7 knockout mice. Sci Signal 2017;10:eaah4874. [PMID: 28074005 DOI: 10.1126/scisignal.aah4874] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
172 Feliszek M, Speckmann V, Schacht D, von Lehe M, Stark H, Schlicker E. A search for functional histamine H4 receptors in the human, guinea pig and mouse brain. Naunyn Schmiedebergs Arch Pharmacol 2015;388:11-7. [PMID: 25300787 DOI: 10.1007/s00210-014-1053-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
173 Feliszek M, Bindila L, Lutz B, Zimmer A, Bilkei-Gorzo A, Schlicker E. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184. Naunyn Schmiedebergs Arch Pharmacol 2016;389:603-12. [PMID: 26984820 DOI: 10.1007/s00210-016-1226-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
174 Schröder W, Lambert DG, Ko MC, Koch T. Functional plasticity of the N/OFQ-NOP receptor system determines analgesic properties of NOP receptor agonists. Br J Pharmacol 2014;171:3777-800. [PMID: 24762001 DOI: 10.1111/bph.12744] [Cited by in Crossref: 81] [Cited by in F6Publishing: 79] [Article Influence: 11.6] [Reference Citation Analysis]
175 Chiellini G, Bellusci L, Sabatini M, Zucchi R. Thyronamines and Analogues - The Route from Rediscovery to Translational Research on Thyronergic Amines. Molecular and Cellular Endocrinology 2017;458:149-55. [DOI: 10.1016/j.mce.2017.01.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
176 Cattaruzza F, Amadesi S, Carlsson JF, Murphy JE, Lyo V, Kirkwood K, Cottrell GS, Bogyo M, Knecht W, Bunnett NW. Serine proteases and protease-activated receptor 2 mediate the proinflammatory and algesic actions of diverse stimulants. Br J Pharmacol. 2014;171:3814-3826. [PMID: 24749982 DOI: 10.1111/bph.12738] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
177 Chabot-Doré AJ, Schuster DJ, Stone LS, Wilcox GL. Analgesic synergy between opioid and α2 -adrenoceptors. Br J Pharmacol 2015;172:388-402. [PMID: 24641506 DOI: 10.1111/bph.12695] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 4.1] [Reference Citation Analysis]
178 Gardella TJ, Vilardaga JP. International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors--family B G protein-coupled receptors. Pharmacol Rev 2015;67:310-37. [PMID: 25713287 DOI: 10.1124/pr.114.009464] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 6.9] [Reference Citation Analysis]
179 Cui ZY, Jo E, Jang HJ, Hwang IH, Lee KB, Yoo HS, Park SJ, Jung MK, Lee YW, Jang IS. Modified Ginseng Extract Induces Apoptosis in HepG2 Cancer Cells by Blocking the CXCL8-Mediated Akt/Nuclear Factor-[Formula: see text]B Signaling Pathway. Am J Chin Med 2018;:1-18. [PMID: 30284465 DOI: 10.1142/S0192415X18500842] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
180 Console-Bram L, Brailoiu E, Brailoiu GC, Sharir H, Abood ME. Activation of GPR18 by cannabinoid compounds: a tale of biased agonism. Br J Pharmacol 2014;171:3908-17. [PMID: 24762058 DOI: 10.1111/bph.12746] [Cited by in Crossref: 86] [Cited by in F6Publishing: 86] [Article Influence: 12.3] [Reference Citation Analysis]
181 Skovsted GF, Kruse LS, Larsen R, Pedersen AF, Trautner S, Sheykhzade M, Edvinsson L. Heart ischaemia-reperfusion induces local up-regulation of vasoconstrictor endothelin ETB receptors in rat coronary arteries downstream of occlusion. Br J Pharmacol 2014;171:2726-38. [PMID: 24467585 DOI: 10.1111/bph.12606] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
182 Cavasotto CN, Palomba D. Expanding the horizons of G protein-coupled receptor structure-based ligand discovery and optimization using homology models. Chem Commun 2015;51:13576-94. [DOI: 10.1039/c5cc05050b] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 5.1] [Reference Citation Analysis]
183 Fujita W, Gomes I, Devi LA. Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10. Br J Pharmacol 2014;171:4155-76. [PMID: 24916280 DOI: 10.1111/bph.12798] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 7.1] [Reference Citation Analysis]
184 Borsotto M, Veyssiere J, Moha Ou Maati H, Devader C, Mazella J, Heurteaux C. Targeting two-pore domain K(+) channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept. Br J Pharmacol 2015;172:771-84. [PMID: 25263033 DOI: 10.1111/bph.12953] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
185 Chen D, Chen Y, Yan Y, Pan J, Xing W, Li Q, Zeng W. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. BMC Cancer 2017;17:553. [PMID: 28821282 DOI: 10.1186/s12885-017-3541-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
186 Bäck M, Powell WS, Dahlén SE, Drazen JM, Evans JF, Serhan CN, Shimizu T, Yokomizo T, Rovati GE. Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7. Br J Pharmacol 2014;171:3551-74. [PMID: 24588652 DOI: 10.1111/bph.12665] [Cited by in Crossref: 129] [Cited by in F6Publishing: 113] [Article Influence: 16.1] [Reference Citation Analysis]
187 Konya V, Maric J, Jandl K, Luschnig P, Aringer I, Lanz I, Platzer W, Theiler A, Bärnthaler T, Frei R, Marsche G, Marsh LM, Olschewski A, Lippe IT, Heinemann A, Schuligoi R. Activation of EP4 receptors prevents endotoxin-induced neutrophil infiltration into the airways and enhances microvascular barrier function. Br J Pharmacol 2015;172:4454-68. [PMID: 26103450 DOI: 10.1111/bph.13229] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
188 Milligan G, Alvarez-Curto E, Watterson KR, Ulven T, Hudson BD. Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4. Br J Pharmacol 2015;172:3254-65. [PMID: 25131623 DOI: 10.1111/bph.12879] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 7.3] [Reference Citation Analysis]
189 Jupp B, Dalley JW. Convergent pharmacological mechanisms in impulsivity and addiction: insights from rodent models. Br J Pharmacol 2014;171:4729-66. [PMID: 24866553 DOI: 10.1111/bph.12787] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
190 Tripathi A, Gaponenko V, Majetschak M. Commercially available antibodies directed against α-adrenergic receptor subtypes and other G protein-coupled receptors with acceptable selectivity in flow cytometry experiments. Naunyn Schmiedebergs Arch Pharmacol 2016;389:243-8. [PMID: 26660071 DOI: 10.1007/s00210-015-1196-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
191 Buneman P, Christie G, Davies JA, Dimitrellou R, Harding SD, Pawson AJ, Sharman JL, Wu Y. Why data citation isn't working, and what to do about it. Database (Oxford) 2020;2020:baaa022. [PMID: 32367113 DOI: 10.1093/databa/baaa022] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
192 Milando R, Friedman A. Cannabinoids: Potential Role in Inflammatory and Neoplastic Skin Diseases. Am J Clin Dermatol 2019;20:167-80. [PMID: 30542832 DOI: 10.1007/s40257-018-0410-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
193 Shishikura K, Horiuchi T, Sakata N, Trinh DA, Shirakawa R, Kimura T, Asada Y, Horiuchi H. Prostaglandin E2 inhibits neutrophil extracellular trap formation through production of cyclic AMP. Br J Pharmacol 2016;173:319-31. [PMID: 26505736 DOI: 10.1111/bph.13373] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
194 Bashashati M, Nasser Y, Keenan CM, Ho W, Piscitelli F, Nalli M, Mackie K, Storr MA, Di Marzo V, Sharkey KA. Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation. Br J Pharmacol 2015;172:3099-111. [PMID: 25684407 DOI: 10.1111/bph.13114] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
195 Simonson B, Morani AS, Ewald AW, Walker L, Kumar N, Simpson D, Miller JH, Prisinzano TE, Kivell BM. Pharmacology and anti-addiction effects of the novel κ opioid receptor agonist Mesyl Sal B, a potent and long-acting analogue of salvinorin A. Br J Pharmacol 2015;172:515-31. [PMID: 24641310 DOI: 10.1111/bph.12692] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
196 Hansen LS, Sparre-Ulrich AH, Christensen M, Knop FK, Hartmann B, Holst JJ, Rosenkilde MM. N-terminally and C-terminally truncated forms of glucose-dependent insulinotropic polypeptide are high-affinity competitive antagonists of the human GIP receptor. Br J Pharmacol 2016;173:826-38. [PMID: 26572091 DOI: 10.1111/bph.13384] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 8.0] [Reference Citation Analysis]
197 Ivonnet P, Salathe M, Conner GE. Hydrogen peroxide stimulation of CFTR reveals an Epac-mediated, soluble AC-dependent cAMP amplification pathway common to GPCR signalling. Br J Pharmacol 2015;172:173-84. [PMID: 25220136 DOI: 10.1111/bph.12934] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
198 Deiteren A, De Man JG, Pelckmans PA, De Winter BY. Histamine H₄ receptors in the gastrointestinal tract. Br J Pharmacol 2015;172:1165-78. [PMID: 25363289 DOI: 10.1111/bph.12989] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 4.6] [Reference Citation Analysis]
199 Lu XZ, Bi XY, He X, Zhao M, Xu M, Yu XJ, Zhao ZH, Zang WJ. Activation of M3 cholinoceptors attenuates vascular injury after ischaemia/reperfusion by inhibiting the Ca2+/calmodulin-dependent protein kinase II pathway. Br J Pharmacol 2015;172:5619-33. [PMID: 25953628 DOI: 10.1111/bph.13183] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
200 Toguri JT, Lehmann C, Laprairie RB, Szczesniak AM, Zhou J, Denovan-Wright EM, Kelly ME. Anti-inflammatory effects of cannabinoid CB(2) receptor activation in endotoxin-induced uveitis. Br J Pharmacol. 2014;171:1448-1461. [PMID: 24308861 DOI: 10.1111/bph.12545] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 6.4] [Reference Citation Analysis]
201 Fallahshahroudi A, Løtvedt P, Bélteky J, Altimiras J, Jensen P. Changes in pituitary gene expression may underlie multiple domesticated traits in chickens. Heredity (Edinb) 2019;122:195-204. [PMID: 29789643 DOI: 10.1038/s41437-018-0092-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
202 Orihuela R, McPherson CA, Harry GJ. Microglial M1/M2 polarization and metabolic states. Br J Pharmacol 2016;173:649-65. [PMID: 25800044 DOI: 10.1111/bph.13139] [Cited by in Crossref: 587] [Cited by in F6Publishing: 597] [Article Influence: 83.9] [Reference Citation Analysis]
203 Cerina M, Szkudlarek HJ, Coulon P, Meuth P, Kanyshkova T, Nguyen XV, Göbel K, Seidenbecher T, Meuth SG, Pape HC, Budde T. Thalamic Kv 7 channels: pharmacological properties and activity control during noxious signal processing. Br J Pharmacol 2015;172:3126-40. [PMID: 25684311 DOI: 10.1111/bph.13113] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
204 Wu CY, Lin MW, Wu DC, Huang YB, Huang HT, Chen CL. The role of phosphoinositide-regulated actin reorganization in chemotaxis and cell migration. Br J Pharmacol 2014;171:5541-54. [PMID: 25420930 DOI: 10.1111/bph.12777] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
205 Cooke AE, Oldfield S, Krasel C, Mundell SJ, Henderson G, Kelly E. Morphine-induced internalization of the L83I mutant of the rat μ-opioid receptor. Br J Pharmacol 2015;172:593-605. [PMID: 24697554 DOI: 10.1111/bph.12709] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
206 Yuan Y, Bai X, Luo C, Wang K, Zhang H. The virtual heart as a platform for screening drug cardiotoxicity. Br J Pharmacol 2015;172:5531-47. [PMID: 25363597 DOI: 10.1111/bph.12996] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
207 Alquicer G, Doležal V, El-fakahany EE. Utilization of Superfused Cerebral Slices in Probing Muscarinic Receptor Autoregulation of Acetylcholine Release. In: Myslivecek J, Jakubik J, editors. Muscarinic Receptor: From Structure to Animal Models. New York: Springer; 2016. pp. 221-33. [DOI: 10.1007/978-1-4939-2858-3_12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
208 Arif S, Borgognone A, Lin EL, O'Sullivan AG, Sharma V, Drury NE, Menon A, Nightingale P, Mascaro J, Bonser RS, Horowitz JD, Feelisch M, Frenneaux MP, Madhani M. Role of aldehyde dehydrogenase in hypoxic vasodilator effects of nitrite in rats and humans. Br J Pharmacol 2015;172:3341-52. [PMID: 25754766 DOI: 10.1111/bph.13122] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
209 Rizzi A, Sukhtankar DD, Ding H, Hayashida K, Ruzza C, Guerrini R, Calò G, Ko MC. Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys. Br J Pharmacol 2015;172:3661-70. [PMID: 25828800 DOI: 10.1111/bph.13150] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
210 Evans AE, Vana PG, LaPorte HM, Kennedy RH, Gamelli RL, Majetschak M. Cardiovascular Responsiveness to Vasopressin and α1-Adrenergic Receptor Agonists After Burn Injury. J Burn Care Res 2017;38:90-8. [PMID: 28045780 DOI: 10.1097/BCR.0000000000000374] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
211 Isensee J, van Cann M, Despang P, Araldi D, Moeller K, Petersen J, Schmidtko A, Matthes J, Levine JD, Hucho T. Depolarization induces nociceptor sensitization by CaV1.2-mediated PKA-II activation. J Cell Biol 2021;220:e202002083. [PMID: 34431981 DOI: 10.1083/jcb.202002083] [Reference Citation Analysis]
212 Gruden G, Barutta F, Kunos G, Pacher P. Role of the endocannabinoid system in diabetes and diabetic complications. Br J Pharmacol 2016;173:1116-27. [PMID: 26076890 DOI: 10.1111/bph.13226] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 10.9] [Reference Citation Analysis]
213 Hwaiz R, Rahman M, Zhang E, Thorlacius H. Platelet secretion of CXCL4 is Rac1-dependent and regulates neutrophil infiltration and tissue damage in septic lung damage. Br J Pharmacol 2015;172:5347-59. [PMID: 26478565 DOI: 10.1111/bph.13325] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
214 Guo D, Venhorst SN, Massink A, van Veldhoven JP, Vauquelin G, IJzerman AP, Heitman LH. Molecular mechanism of allosteric modulation at GPCRs: insight from a binding kinetics study at the human A1 adenosine receptor. Br J Pharmacol 2014;171:5295-312. [PMID: 25040887 DOI: 10.1111/bph.12836] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
215 Doornbos ML, Pérez-Benito L, Tresadern G, Mulder-Krieger T, Biesmans I, Trabanco AA, Cid JM, Lavreysen H, IJzerman AP, Heitman LH. Molecular mechanism of positive allosteric modulation of the metabotropic glutamate receptor 2 by JNJ-46281222. Br J Pharmacol 2016;173:588-600. [PMID: 26589404 DOI: 10.1111/bph.13390] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 5.2] [Reference Citation Analysis]
216 Dong M, Koole C, Wootten D, Sexton PM, Miller LJ. Structural and functional insights into the juxtamembranous amino-terminal tail and extracellular loop regions of class B GPCRs. Br J Pharmacol 2014;171:1085-101. [PMID: 23889342 DOI: 10.1111/bph.12293] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
217 Laurent V, Wong FL, Balleine BW. δ-Opioid receptors in the accumbens shell mediate the influence of both excitatory and inhibitory predictions on choice. Br J Pharmacol 2015;172:562-70. [PMID: 24758591 DOI: 10.1111/bph.12731] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
218 Gherbi K, Briddon SJ, Hill SJ. Detection of the secondary, low-affinity β1 -adrenoceptor site in living cells using the fluorescent CGP 12177 derivative BODIPY-TMR-CGP. Br J Pharmacol 2014;171:5431-45. [PMID: 25052258 DOI: 10.1111/bph.12858] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
219 Meng G, Ma Y, Xie L, Ferro A, Ji Y. Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases. Br J Pharmacol 2015;172:5501-11. [PMID: 25204754 DOI: 10.1111/bph.12900] [Cited by in Crossref: 68] [Cited by in F6Publishing: 68] [Article Influence: 8.5] [Reference Citation Analysis]
220 Karve IP, Taylor JM, Crack PJ. The contribution of astrocytes and microglia to traumatic brain injury. Br J Pharmacol 2016;173:692-702. [PMID: 25752446 DOI: 10.1111/bph.13125] [Cited by in Crossref: 227] [Cited by in F6Publishing: 223] [Article Influence: 32.4] [Reference Citation Analysis]
221 Farinha A, Lavreysen H, Peeters L, Russo B, Masure S, Trabanco AA, Cid J, Tresadern G. Molecular determinants of positive allosteric modulation of the human metabotropic glutamate receptor 2. Br J Pharmacol 2015;172:2383-96. [PMID: 25571949 DOI: 10.1111/bph.13065] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
222 Beaudry H, Mercier-Blais AA, Delaygue C, Lavoie C, Parent JL, Neugebauer W, Gendron L. Regulation of μ and δ opioid receptor functions: involvement of cyclin-dependent kinase 5. Br J Pharmacol 2015;172:2573-87. [PMID: 25598508 DOI: 10.1111/bph.13088] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
223 Sparre-Ulrich AH, Hansen LS, Svendsen B, Christensen M, Knop FK, Hartmann B, Holst JJ, Rosenkilde MM. Species-specific action of (Pro3)GIP - a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors. Br J Pharmacol 2016;173:27-38. [PMID: 26359804 DOI: 10.1111/bph.13323] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 7.1] [Reference Citation Analysis]
224 Faden AI, Wu J, Stoica BA, Loane DJ. Progressive inflammation-mediated neurodegeneration after traumatic brain or spinal cord injury. Br J Pharmacol 2016;173:681-91. [PMID: 25939377 DOI: 10.1111/bph.13179] [Cited by in Crossref: 142] [Cited by in F6Publishing: 136] [Article Influence: 20.3] [Reference Citation Analysis]
225 Ramachandran R, Altier C, Oikonomopoulou K, Hollenberg MD. Proteinases, Their Extracellular Targets, and Inflammatory Signaling. Pharmacol Rev 2016;68:1110-42. [PMID: 27677721 DOI: 10.1124/pr.115.010991] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
226 Musilli C, De Siena G, Manni ME, Logli A, Landucci E, Zucchi R, Saba A, Donzelli R, Passani MB, Provensi G, Raimondi L. Histamine mediates behavioural and metabolic effects of 3-iodothyroacetic acid, an endogenous end product of thyroid hormone metabolism. Br J Pharmacol 2014;171:3476-84. [PMID: 24641572 DOI: 10.1111/bph.12697] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
227 Fujita W, Gomes I, Devi LA. Heteromers of μ-δ opioid receptors: new pharmacology and novel therapeutic possibilities. Br J Pharmacol 2015;172:375-87. [PMID: 24571499 DOI: 10.1111/bph.12663] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 7.6] [Reference Citation Analysis]
228 Stumpf AD, Hoffmann C. Optical probes based on G protein-coupled receptors - added work or added value? Br J Pharmacol 2016;173:255-66. [PMID: 26562218 DOI: 10.1111/bph.13382] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
229 Liang J, Tong P, Li J. Research and Application of Glycoprotein Sensors Based on Glycosyl Recognition. Chinese Journal of Analytical Chemistry 2019;47:1283-92. [DOI: 10.1016/s1872-2040(19)61185-0] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
230 Stoddart LA, Kellam B, Briddon SJ, Hill SJ. Effect of a toggle switch mutation in TM6 of the human adenosine A₃ receptor on Gi protein-dependent signalling and Gi-independent receptor internalization. Br J Pharmacol 2014;171:3827-44. [PMID: 24750014 DOI: 10.1111/bph.12739] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
231 Champeroux P, Le Guennec JY, Jude S, Laigot C, Maurin A, Sola ML, Fowler JS, Richard S, Thireau J. The high frequency relationship: implications for torsadogenic hERG blockers. Br J Pharmacol 2016;173:601-12. [PMID: 26589499 DOI: 10.1111/bph.13391] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
232 Wang X, Cheang WS, Yang H, Xiao L, Lai B, Zhang M, Ni J, Luo Z, Zhang Z, Huang Y, Wang N. Nuciferine relaxes rat mesenteric arteries through endothelium-dependent and -independent mechanisms. Br J Pharmacol 2015;172:5609-18. [PMID: 25409881 DOI: 10.1111/bph.13021] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
233 de Guglielmo G, Kallupi M, Scuppa G, Stopponi S, Demopulos G, Gaitanaris G, Ciccocioppo R. Analgesic tolerance to morphine is regulated by PPARγ. Br J Pharmacol 2014;171:5407-16. [PMID: 25048682 DOI: 10.1111/bph.12851] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
234 Wu R, Zhou W, Chen S, Shi Y, Su L, Zhu M, Chen Q, Chen Q. Lipoxin A4 suppresses the development of endometriosis in an ALX receptor-dependent manner via the p38 MAPK pathway. Br J Pharmacol 2014;171:4927-40. [PMID: 24923883 DOI: 10.1111/bph.12816] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
235 Petrosino S, Schiano Moriello A, Cerrato S, Fusco M, Puigdemont A, De Petrocellis L, Di Marzo V. The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at TRPV1 cation channels. Br J Pharmacol 2016;173:1154-62. [PMID: 25598150 DOI: 10.1111/bph.13084] [Cited by in Crossref: 63] [Cited by in F6Publishing: 69] [Article Influence: 9.0] [Reference Citation Analysis]
236 Oh KS, Lee JH, Yi KY, Lim CJ, Lee S, Park CH, Seo HW, Lee BH. The orally active urotensin receptor antagonist, KR36676, attenuates cellular and cardiac hypertrophy. Br J Pharmacol 2015;172:2618-33. [PMID: 25597918 DOI: 10.1111/bph.13082] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
237 Yin Q, Lu H, Bai Y, Tian A, Yang Q, Wu J, Yang C, Fan TP, Zhang Y, Zheng X, Zheng X, Li Z. A metabolite of Danshen formulae attenuates cardiac fibrosis induced by isoprenaline, via a NOX2/ROS/p38 pathway. Br J Pharmacol 2015;172:5573-85. [PMID: 25766073 DOI: 10.1111/bph.13133] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
238 Cheang WS, Tian XY, Wong WT, Huang Y. The peroxisome proliferator-activated receptors in cardiovascular diseases: experimental benefits and clinical challenges. Br J Pharmacol 2015;172:5512-22. [PMID: 25438608 DOI: 10.1111/bph.13029] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
239 Afsharimani B, Doornebal CW, Cabot PJ, Hollmann MW, Parat MO. Comparison and analysis of the animal models used to study the effect of morphine on tumour growth and metastasis. Br J Pharmacol. 2015;172:251-259. [PMID: 24467261 DOI: 10.1111/bph.12589] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
240 Kukkonen JP. G-protein inhibition profile of the reported Gq/11 inhibitor UBO-QIC. Biochem Biophys Res Commun 2016;469:101-7. [PMID: 26614908 DOI: 10.1016/j.bbrc.2015.11.078] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
241 Zhang L, Eiden LE. Two ancient neuropeptides, PACAP and AVP, modulate motivated behavior at synapses in the extrahypothalamic brain: a study in contrast. Cell Tissue Res 2019;375:103-22. [DOI: 10.1007/s00441-018-2958-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
242 Wilson-Poe AR, Lau BK, Vaughan CW. Repeated morphine treatment alters cannabinoid modulation of GABAergic synaptic transmission within the rat periaqueductal grey. Br J Pharmacol 2015;172:681-90. [PMID: 24916363 DOI: 10.1111/bph.12809] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
243 Milić D, Veprintsev DB. Large-scale production and protein engineering of G protein-coupled receptors for structural studies. Front Pharmacol 2015;6:66. [PMID: 25873898 DOI: 10.3389/fphar.2015.00066] [Cited by in Crossref: 14] [Cited by in F6Publishing: 24] [Article Influence: 2.0] [Reference Citation Analysis]
244 Ruzza C, Rizzi A, Malfacini D, Cerlesi MC, Ferrari F, Marzola E, Ambrosio C, Gro C, Severo S, Costa T, Calo G, Guerrini R. Pharmacological characterization of tachykinin tetrabranched derivatives. Br J Pharmacol 2014;171:4125-37. [PMID: 24758475 DOI: 10.1111/bph.12727] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
245 Borrelli F, Romano B, Petrosino S, Pagano E, Capasso R, Coppola D, Battista G, Orlando P, Di Marzo V, Izzo AA. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent. Br J Pharmacol. 2015;172:142-158. [PMID: 25205418 DOI: 10.1111/bph.12907] [Cited by in Crossref: 83] [Cited by in F6Publishing: 83] [Article Influence: 10.4] [Reference Citation Analysis]
246 Pan ZW, Lu YJ, Yang BF. Advances in exploring the role of microRNAs in the pathogenesis, diagnosis and therapy of cardiac diseases in China. Br J Pharmacol 2015;172:5435-43. [PMID: 25393505 DOI: 10.1111/bph.13015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
247 Alexandre EC, Kiguti LR, Calmasini FB, Silva FH, da Silva KP, Ferreira R, Ribeiro CA, Mónica FZ, Pupo AS, Antunes E. Mirabegron relaxes urethral smooth muscle by a dual mechanism involving β3 -adrenoceptor activation and α1 -adrenoceptor blockade. Br J Pharmacol 2016;173:415-28. [PMID: 26493129 DOI: 10.1111/bph.13367] [Cited by in Crossref: 41] [Cited by in F6Publishing: 32] [Article Influence: 6.8] [Reference Citation Analysis]
248 Kokras N, Dalla C. Sex differences in animal models of psychiatric disorders. Br J Pharmacol 2014;171:4595-619. [PMID: 24697577 DOI: 10.1111/bph.12710] [Cited by in Crossref: 162] [Cited by in F6Publishing: 151] [Article Influence: 20.3] [Reference Citation Analysis]
249 Thanawala VJ, Valdez DJ, Joshi R, Forkuo GS, Parra S, Knoll BJ, Bouvier M, Leff P, Bond RA. β-Blockers have differential effects on the murine asthma phenotype. Br J Pharmacol 2015;172:4833-46. [PMID: 26211486 DOI: 10.1111/bph.13253] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
250 Swinney DC, Beavis P, Chuang KT, Zheng Y, Lee I, Gee P, Deval J, Rotstein DM, Dioszegi M, Ravendran P, Zhang J, Sankuratri S, Kondru R, Vauquelin G. A study of the molecular mechanism of binding kinetics and long residence times of human CCR5 receptor small molecule allosteric ligands. Br J Pharmacol 2014;171:3364-75. [PMID: 24628038 DOI: 10.1111/bph.12683] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 5.9] [Reference Citation Analysis]
251 Sheng Y, Sun B, Guo WT, Liu X, Wang YC, Xie X, Xiao XL, Li N, Dong DL. (4-[6-(4-isopropoxyphenyl)pyrazolo [1,5-a]pyrimidin-3-yl] quinoline) is a novel inhibitor of autophagy. Br J Pharmacol 2014;171:4970-80. [PMID: 24943256 DOI: 10.1111/bph.12821] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
252 García C, Palomo-Garo C, Gómez-Gálvez Y, Fernández-Ruiz J. Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia. Br J Pharmacol 2016;173:2069-79. [PMID: 26059564 DOI: 10.1111/bph.13215] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
253 Vauquelin G, Hall D, Charlton SJ. 'Partial' competition of heterobivalent ligand binding may be mistaken for allosteric interactions: a comparison of different target interaction models. Br J Pharmacol 2015;172:2300-15. [PMID: 25537684 DOI: 10.1111/bph.13053] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
254 Jamdade VS, Sethi N, Mundhe NA, Kumar P, Lahkar M, Sinha N. Therapeutic targets of triple-negative breast cancer: a review. Br J Pharmacol. 2015;172:4228-4237. [PMID: 26040571 DOI: 10.1111/bph.13211] [Cited by in Crossref: 94] [Cited by in F6Publishing: 95] [Article Influence: 13.4] [Reference Citation Analysis]
255 Alburquerque-González B, López-Calderón FF, López-Abellán MD, Esteban-Gil Á, García-Solano J, Conesa-Zamora P. Biology and Therapeutic Targets of Colorectal Serrated Adenocarcinoma; Clues for a Histologically Based Treatment against an Aggressive Tumor. Int J Mol Sci 2020;21:E1991. [PMID: 32183342 DOI: 10.3390/ijms21061991] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
256 Kaiser D, Oetjen E. Something old, something new and something very old: drugs for treating type 2 diabetes. Br J Pharmacol 2014;171:2940-50. [PMID: 24641580 DOI: 10.1111/bph.12624] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
257 Hernanz R, Martínez-Revelles S, Palacios R, Martín A, Cachofeiro V, Aguado A, García-Redondo L, Barrús MT, de Batista PR, Briones AM, Salaices M, Alonso MJ. Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension. Br J Pharmacol 2015;172:3159-76. [PMID: 25712370 DOI: 10.1111/bph.13117] [Cited by in Crossref: 88] [Cited by in F6Publishing: 86] [Article Influence: 12.6] [Reference Citation Analysis]
258 Kaji I, Akiba Y, Said H, Narimatsu K, Kaunitz JD. Luminal 5-HT stimulates colonic bicarbonate secretion in rats. Br J Pharmacol 2015;172:4655-70. [PMID: 26061462 DOI: 10.1111/bph.13216] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
259 Tate M, Chong A, Robinson E, Green BD, Grieve DJ. Selective targeting of glucagon-like peptide-1 signalling as a novel therapeutic approach for cardiovascular disease in diabetes. Br J Pharmacol 2015;172:721-36. [PMID: 25231355 DOI: 10.1111/bph.12943] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
260 Pradhan AA, Smith ML, Zyuzin J, Charles A. δ-Opioid receptor agonists inhibit migraine-related hyperalgesia, aversive state and cortical spreading depression in mice. Br J Pharmacol 2014;171:2375-84. [PMID: 24467301 DOI: 10.1111/bph.12591] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 7.4] [Reference Citation Analysis]
261 Gil-Ortega M, García-Prieto CF, Ruiz-Hurtado G, Steireif C, González MC, Schulz A, Kreutz R, Fernández-Alfonso MS, Arribas S, Somoza B. Genetic predisposition to albuminuria is associated with increased arterial stiffness: role of elastin. Br J Pharmacol 2015;172:4406-18. [PMID: 26075500 DOI: 10.1111/bph.13223] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
262 Guan NN, Svennersten K, de Verdier PJ, Wiklund NP, Gustafsson LE. Receptors involved in the modulation of guinea pig urinary bladder motility by prostaglandin D2. Br J Pharmacol 2015;172:4024-37. [PMID: 25917171 DOI: 10.1111/bph.13174] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
263 Smarius LJCA, Strieder TGA, Doreleijers TAH, Vrijkotte TGM, Zafarmand MH, de Rooij SR. Common oxytocin polymorphisms interact with maternal verbal aggression in early infancy impacting blood pressure at age 5-6: The ABCD study. PLoS One 2019;14:e0216035. [PMID: 31233509 DOI: 10.1371/journal.pone.0216035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
264 van Goethem NP, Schreiber R, Newman-Tancredi A, Varney M, Prickaerts J. Divergent effects of the 'biased' 5-HT1 A receptor agonists F15599 and F13714 in a novel object pattern separation task. Br J Pharmacol 2015;172:2532-43. [PMID: 25572672 DOI: 10.1111/bph.13071] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
265 Bryant CE, Orr S, Ferguson B, Symmons MF, Boyle JP, Monie TP. International Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and disease. Pharmacol Rev 2015;67:462-504. [PMID: 25829385 DOI: 10.1124/pr.114.009928] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 4.4] [Reference Citation Analysis]
266 Fornai M, Colucci R, Antonioli L, Ippolito C, Segnani C, Buccianti P, Marioni A, Chiarugi M, Villanacci V, Bassotti G, Blandizzi C, Bernardini N. Role of cyclooxygenase isoforms in the altered excitatory motor pathways of human colon with diverticular disease. Br J Pharmacol 2014;171:3728-40. [PMID: 24758697 DOI: 10.1111/bph.12733] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
267 Tóth BI, Oláh A, Szöllősi AG, Bíró T. TRP channels in the skin. Br J Pharmacol 2014;171:2568-81. [PMID: 24372189 DOI: 10.1111/bph.12569] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 7.4] [Reference Citation Analysis]
268 Heger J, Schulz R, Euler G. Molecular switches under TGFβ signalling during progression from cardiac hypertrophy to heart failure. Br J Pharmacol 2016;173:3-14. [PMID: 26431212 DOI: 10.1111/bph.13344] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
269 Smit KF, Weber NC, Hollmann MW, Preckel B. Noble gases as cardioprotectants - translatability and mechanism. Br J Pharmacol 2015;172:2062-73. [PMID: 25363501 DOI: 10.1111/bph.12994] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
270 Pinkney AM, Lemmey HA, Dora KA, Garland CJ. Vasorelaxation to the Nitroxyl Donor Isopropylamine NONOate in Resistance Arteries Does Not Require Perivascular Calcitonin Gene–Related Peptide. Hypertension 2017;70:587-93. [DOI: 10.1161/hypertensionaha.117.09737] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
271 Paul AK, Smith CM, Rahmatullah M, Nissapatorn V, Wilairatana P, Spetea M, Gueven N, Dietis N. Opioid Analgesia and Opioid-Induced Adverse Effects: A Review. Pharmaceuticals (Basel) 2021;14:1091. [PMID: 34832873 DOI: 10.3390/ph14111091] [Reference Citation Analysis]
272 Toczek M, Schlicker E, Grzęda E, Malinowska B. Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive rats. Life Sci 2015;138:78-85. [PMID: 25921770 DOI: 10.1016/j.lfs.2015.03.022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
273 Zhang X, Bao L, Li S. Opioid receptor trafficking and interaction in nociceptors. Br J Pharmacol 2015;172:364-74. [PMID: 24611685 DOI: 10.1111/bph.12653] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
274 Zhao Y, Vanhoutte PM, Leung SW. α1 -Adrenoceptor activation of PKC-ε causes heterologous desensitization of thromboxane receptors in the aorta of spontaneously hypertensive rats. Br J Pharmacol 2015;172:3687-701. [PMID: 25857252 DOI: 10.1111/bph.13157] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
275 Dick AL, Simpson A, Qama A, Andrews Z, Lawrence AJ, Duncan JR. Chronic intermittent toluene inhalation in adolescent rats results in metabolic dysfunction with altered glucose homeostasis. Br J Pharmacol 2015;172:5174-87. [PMID: 26282596 DOI: 10.1111/bph.13284] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
276 Maguire JJ, Davenport AP. Endothelin@25 - new agonists, antagonists, inhibitors and emerging research frontiers: IUPHAR Review 12. Br J Pharmacol 2014;171:5555-72. [PMID: 25131455 DOI: 10.1111/bph.12874] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
277 Khan D, Vasu S, Moffett RC, Irwin N, Flatt PR. Influence of neuropeptide Y and pancreatic polypeptide on islet function and beta-cell survival. Biochim Biophys Acta Gen Subj 2017;1861:749-58. [PMID: 28069397 DOI: 10.1016/j.bbagen.2017.01.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
278 Liang J, Chao D, Sandhu HK, Yu Y, Zhang L, Balboni G, Kim DH, Xia Y. δ-Opioid receptors up-regulate excitatory amino acid transporters in mouse astrocytes. Br J Pharmacol 2014;171:5417-30. [PMID: 25052197 DOI: 10.1111/bph.12857] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
279 Krishnan SM, Sobey CG, Latz E, Mansell A, Drummond GR. IL-1β and IL-18: inflammatory markers or mediators of hypertension? Br J Pharmacol 2014;171:5589-602. [PMID: 25117218 DOI: 10.1111/bph.12876] [Cited by in Crossref: 99] [Cited by in F6Publishing: 100] [Article Influence: 14.1] [Reference Citation Analysis]
280 Loma P, Guzman-Aranguez A, Pérez de Lara MJ, Pintor J. Diadenosine tetraphosphate induces tight junction disassembly thus increasing corneal epithelial permeability. Br J Pharmacol 2015;172:1045-58. [PMID: 25297531 DOI: 10.1111/bph.12972] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
281 Kikuchi C, Dosenovic S, Bienengraeber M. Anaesthetics as cardioprotectants: translatability and mechanism. Br J Pharmacol 2015;172:2051-61. [PMID: 25322898 DOI: 10.1111/bph.12981] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
282 Ganella DE, Kim JH. Developmental rodent models of fear and anxiety: from neurobiology to pharmacology. Br J Pharmacol 2014;171:4556-74. [PMID: 24527726 DOI: 10.1111/bph.12643] [Cited by in Crossref: 59] [Cited by in F6Publishing: 47] [Article Influence: 7.4] [Reference Citation Analysis]
283 Prenderville JA, Kelly ÁM, Downer EJ. The role of cannabinoids in adult neurogenesis. Br J Pharmacol 2015;172:3950-63. [PMID: 25951750 DOI: 10.1111/bph.13186] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 7.9] [Reference Citation Analysis]
284 Leiser SC, Pehrson AL, Robichaud PJ, Sanchez C. Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine--a quantitative EEG study in rats. Br J Pharmacol 2014;171:4255-72. [PMID: 24846338 DOI: 10.1111/bph.12782] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.7] [Reference Citation Analysis]
285 Kao W, Gu R, Jia Y, Wei X, Fan H, Harris J, Zhang Z, Quinn J, Morand EF, Yang YH. A formyl peptide receptor agonist suppresses inflammation and bone damage in arthritis. Br J Pharmacol 2014;171:4087-96. [PMID: 24824742 DOI: 10.1111/bph.12768] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 5.6] [Reference Citation Analysis]
286 Cobret L, De Tauzia ML, Ferent J, Traiffort E, Hénaoui I, Godin F, Kellenberger E, Rognan D, Pantel J, Bénédetti H, Morisset-Lopez S. Targeting the cis-dimerization of LINGO-1 with low MW compounds affects its downstream signalling. Br J Pharmacol 2015;172:841-56. [PMID: 25257685 DOI: 10.1111/bph.12945] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
287 Rinaldi B, Donniacuo M, Sodano L, Gritti G, Martuscelli E, Orlandi A, Rafaniello C, Rossi F, Calzetta L, Capuano A, Matera MG. Effects of chronic treatment with the new ultra-long-acting β2 -adrenoceptor agonist indacaterol alone or in combination with the β1 -adrenoceptor blocker metoprolol on cardiac remodelling. Br J Pharmacol 2015;172:3627-37. [PMID: 25825265 DOI: 10.1111/bph.13148] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
288 Wex E, Kollak I, Duechs MJ, Naline E, Wollin L, Devillier P. The long-acting β2 -adrenoceptor agonist olodaterol attenuates pulmonary inflammation. Br J Pharmacol 2015;172:3537-47. [PMID: 25824824 DOI: 10.1111/bph.13143] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
289 Bruce E, Shenoy V, Rathinasabapathy A, Espejo A, Horowitz A, Oswalt A, Francis J, Nair A, Unger T, Raizada MK, Steckelings UM, Sumners C, Katovich MJ. Selective activation of angiotensin AT2 receptors attenuates progression of pulmonary hypertension and inhibits cardiopulmonary fibrosis. Br J Pharmacol 2015;172:2219-31. [PMID: 25522140 DOI: 10.1111/bph.13044] [Cited by in Crossref: 52] [Cited by in F6Publishing: 55] [Article Influence: 7.4] [Reference Citation Analysis]
290 Zhu Y, Lu Y, Qu C, Miller M, Tian J, Thakur DP, Zhu J, Deng Z, Hu X, Wu M, McManus OB, Li M, Hong X, Zhu MX, Luo HR. Identification and optimization of 2-aminobenzimidazole derivatives as novel inhibitors of TRPC4 and TRPC5 channels. Br J Pharmacol 2015;172:3495-509. [PMID: 25816897 DOI: 10.1111/bph.13140] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
291 Crowe MS, Leishman E, Banks ML, Gujjar R, Mahadevan A, Bradshaw HB, Kinsey SG. Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice. Br J Pharmacol 2015;172:1700-12. [PMID: 25393148 DOI: 10.1111/bph.13012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
292 Przyklenk K. Ischaemic conditioning: pitfalls on the path to clinical translation. Br J Pharmacol 2015;172:1961-73. [PMID: 25560903 DOI: 10.1111/bph.13064] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
293 Ceredig RA, Massotte D. Fluorescent knock-in mice to decipher the physiopathological role of G protein-coupled receptors. Front Pharmacol 2014;5:289. [PMID: 25610398 DOI: 10.3389/fphar.2014.00289] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
294 Taylor AM, Roberts KW, Pradhan AA, Akbari HA, Walwyn W, Lutfy K, Carroll FI, Cahill CM, Evans CJ. Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist. Br J Pharmacol 2015;172:691-703. [PMID: 24923251 DOI: 10.1111/bph.12810] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
295 Nøhr AC, Jespers W, Shehata MA, Floryan L, Isberg V, Andersen KB, Åqvist J, Gutiérrez-de-Terán H, Bräuner-Osborne H, Gloriam DE. The GPR139 reference agonists 1a and 7c, and tryptophan and phenylalanine share a common binding site. Sci Rep 2017;7:1128. [PMID: 28442765 DOI: 10.1038/s41598-017-01049-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
296 Mann A, Illing S, Miess E, Schulz S. Different mechanisms of homologous and heterologous μ-opioid receptor phosphorylation. Br J Pharmacol 2015;172:311-6. [PMID: 24517854 DOI: 10.1111/bph.12627] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
297 Madishetti S, Schneble N, König C, Hirsch E, Schulz S, Müller JP, Wetzker R. PI3Kγ integrates cAMP and Akt signalling of the μ-opioid receptor. Br J Pharmacol 2014;171:3328-37. [PMID: 24654606 DOI: 10.1111/bph.12698] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
298 Nataraja SG, Yu HN, Palmer SS. Discovery and Development of Small Molecule Allosteric Modulators of Glycoprotein Hormone Receptors. Front Endocrinol (Lausanne) 2015;6:142. [PMID: 26441832 DOI: 10.3389/fendo.2015.00142] [Cited by in Crossref: 37] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
299 Masuoka T, Nakamura T, Kudo M, Yoshida J, Takaoka Y, Kato N, Ishibashi T, Imaizumi N, Nishio M. Biphasic modulation by mGlu5 receptors of TRPV1-mediated intracellular calcium elevation in sensory neurons contributes to heat sensitivity. Br J Pharmacol 2015;172:1020-33. [PMID: 25297838 DOI: 10.1111/bph.12962] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
300 Boitano S, Hoffman J, Flynn AN, Asiedu MN, Tillu DV, Zhang Z, Sherwood CL, Rivas CM, DeFea KA, Vagner J, Price TJ. The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo. Br J Pharmacol 2015;172:4535-45. [PMID: 26140338 DOI: 10.1111/bph.13238] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
301 Chu S, Xiong W, Parkinson FE. Effect of ecto-5'-nucleotidase (eN) in astrocytes on adenosine and inosine formation. Purinergic Signal 2014;10:603-9. [PMID: 25129451 DOI: 10.1007/s11302-014-9421-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
302 Kozuka C, Sunagawa S, Ueda R, Higa M, Ohshiro Y, Tanaka H, Shimizu-Okabe C, Takayama C, Matsushita M, Tsutsui M, Ishiuchi S, Nakata M, Yada T, Miyazaki JI, Oyadomari S, Shimabukuro M, Masuzaki H. A novel insulinotropic mechanism of whole grain-derived γ-oryzanol via the suppression of local dopamine D2 receptor signalling in mouse islet. Br J Pharmacol 2015;172:4519-34. [PMID: 26140534 DOI: 10.1111/bph.13236] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
303 Megat S, Bohren Y, Doridot S, Gaveriaux-Ruff C, Kieffer BL, Freund-Mercier MJ, Yalcin I, Barrot M. κ-Opioid receptors are not necessary for the antidepressant treatment of neuropathic pain. Br J Pharmacol 2015;172:1034-44. [PMID: 25297905 DOI: 10.1111/bph.12963] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
304 Pagliaro P, Penna C. Redox signalling and cardioprotection: translatability and mechanism. Br J Pharmacol 2015;172:1974-95. [PMID: 25303224 DOI: 10.1111/bph.12975] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 6.7] [Reference Citation Analysis]
305 Cox BM, Christie MJ, Devi L, Toll L, Traynor JR. Challenges for opioid receptor nomenclature: IUPHAR Review 9. Br J Pharmacol 2015;172:317-23. [PMID: 24528283 DOI: 10.1111/bph.12612] [Cited by in Crossref: 83] [Cited by in F6Publishing: 73] [Article Influence: 10.4] [Reference Citation Analysis]
306 Cheng PW, Ho WY, Su YT, Lu PJ, Chen BZ, Cheng WH, Lu WH, Sun GC, Yeh TC, Hsiao M. Resveratrol decreases fructose-induced oxidative stress, mediated by NADPH oxidase via an AMPK-dependent mechanism. Br J Pharmacol. 2014;171:2739-2750. [PMID: 24547812 DOI: 10.1111/bph.12648] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 7.0] [Reference Citation Analysis]
307 Corrigan F, Vink R, Turner RJ. Inflammation in acute CNS injury: a focus on the role of substance P. Br J Pharmacol 2016;173:703-15. [PMID: 25827155 DOI: 10.1111/bph.13155] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
308 Panula P, Chazot PL, Cowart M, Gutzmer R, Leurs R, Liu WL, Stark H, Thurmond RL, Haas HL. International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors. Pharmacol Rev 2015;67:601-55. [PMID: 26084539 DOI: 10.1124/pr.114.010249] [Cited by in Crossref: 263] [Cited by in F6Publishing: 240] [Article Influence: 43.8] [Reference Citation Analysis]
309 Cao S, Chao D, Zhou H, Balboni G, Xia Y. A novel mechanism for cytoprotection against hypoxic injury: δ-opioid receptor-mediated increase in Nrf2 translocation. Br J Pharmacol 2015;172:1869-81. [PMID: 25439010 DOI: 10.1111/bph.13031] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
310 Heimlich JB, Speed JS, O'Connor PM, Pollock JS, Townes TM, Meiler SE, Kutlar A, Pollock DM. Endothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species. Br J Pharmacol 2016;173:386-95. [PMID: 26561980 DOI: 10.1111/bph.13380] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
311 Hoyer D. 5-HT Receptor Nomenclature: Naming Names, Does It Matter? A Tribute to Maurice Rapport. ACS Chem Neurosci 2017;8:908-19. [PMID: 28269984 DOI: 10.1021/acschemneuro.7b00011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
312 Crnkovic S, Egemnazarov B, Jain P, Seay U, Gattinger N, Marsh LM, Bálint Z, Kovacs G, Ghanim B, Klepetko W, Schermuly RT, Weissmann N, Olschewski A, Kwapiszewska G. NPY/Y₁ receptor-mediated vasoconstrictory and proliferative effects in pulmonary hypertension. Br J Pharmacol 2014;171:3895-907. [PMID: 24779394 DOI: 10.1111/bph.12751] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 4.1] [Reference Citation Analysis]
313 Zhang GH, Liu ZL, Zhang BJ, Geng WY, Song NN, Zhou W, Cao YX, Li SQ, Huang ZL, Shen LL. Orexin A activates hypoglossal motoneurons and enhances genioglossus muscle activity in rats. Br J Pharmacol 2014;171:4233-46. [PMID: 24846570 DOI: 10.1111/bph.12784] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
314 Echeverry-Alzate V, Giné E, Bühler KM, Calleja-Conde J, Olmos P, Gorriti MA, Nadal R, Rodríguez de Fonseca F, López-Moreno JA. Effects of topiramate on ethanol-cocaine interactions and DNA methyltransferase gene expression in the rat prefrontal cortex. Br J Pharmacol 2014;171:3023-36. [PMID: 24527678 DOI: 10.1111/bph.12636] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
315 Alexander SP. Common Receptors for Endocannabinoid-Like Mediators and Plant Cannabinoids. The Endocannabinoidome. Elsevier; 2015. pp. 153-75. [DOI: 10.1016/b978-0-12-420126-2.00010-9] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
316 Guo L, Chen Y, Zhao R, Wang G, Friedman E, Zhang A, Zhen X. Allosteric modulation of sigma-1 receptors elicits anti-seizure activities. Br J Pharmacol 2015;172:4052-65. [PMID: 25989224 DOI: 10.1111/bph.13195] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
317 Español AJ, Maddaleno MO, Lombardi MG, Cella M, Martínez Pulido P, Sales ME. Treatment with LPS plus INF-γ induces the expression and function of muscarinic acetylcholine receptors, modulating NIH3T3 cell proliferation: participation of NOS and COX. Br J Pharmacol 2014;171:5154-67. [PMID: 24990429 DOI: 10.1111/bph.12834] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
318 Di Francesco L, Dovizio M, Trenti A, Marcantoni E, Moore A, O'Gaora P, McCarthy C, Tacconelli S, Bruno A, Alberti S, Gizzo S, Nardelli GB, Orso G, Belton O, Trevisi L, Dixon DA, Patrignani P. Dysregulated post-transcriptional control of COX-2 gene expression in gestational diabetic endothelial cells. Br J Pharmacol 2015;172:4575-87. [PMID: 26140661 DOI: 10.1111/bph.13241] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
319 Lanza M, Ferrari F, Menghetti I, Tremolada D, Caselli G. Modulation of imidazoline I2 binding sites by CR4056 relieves postoperative hyperalgesia in male and female rats. Br J Pharmacol 2014;171:3693-701. [PMID: 24758515 DOI: 10.1111/bph.12728] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
320 Echeverría E, Cabrera M, Burghi V, Sosa M, Ripoll S, Yaneff A, Monczor F, Davio C, Shayo C, Fernández N. The Regulator of G Protein Signaling Homologous Domain of G Protein-Coupled Receptor Kinase 2 Mediates Short-Term Desensitization of β3-Adrenergic Receptor. Front Pharmacol 2020;11:113. [PMID: 32153413 DOI: 10.3389/fphar.2020.00113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
321 Smith JF, Lemmey HAL, Borysova L, Hiley CR, Dora KA, Garland CJ. Endothelial Nitric Oxide Suppresses Action-Potential-Like Transient Spikes and Vasospasm in Small Resistance Arteries. Hypertension 2020;76:785-94. [PMID: 32713276 DOI: 10.1161/HYPERTENSIONAHA.120.15491] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
322 Stein LM, Tullock CW, Mathews SK, Garcia-Galiano D, Elias CF, Samson WK, Yosten GL. Hypothalamic action of phoenixin to control reproductive hormone secretion in females: importance of the orphan G protein-coupled receptor Gpr173. Am J Physiol Regul Integr Comp Physiol 2016;311:R489-96. [PMID: 27440717 DOI: 10.1152/ajpregu.00191.2016] [Cited by in Crossref: 54] [Cited by in F6Publishing: 50] [Article Influence: 9.0] [Reference Citation Analysis]
323 Ilinskaya AN, Dobrovolskaia MA. Immunosuppressive and anti-inflammatory properties of engineered nanomaterials. Br J Pharmacol 2014;171:3988-4000. [PMID: 24724793 DOI: 10.1111/bph.12722] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 8.0] [Reference Citation Analysis]
324 Vestmar MA, Andersson EA, Christensen CR, Hauge M, Glümer C, Linneberg A, Witte DR, Jørgensen ME, Christensen C, Brandslund I, Lauritzen T, Pedersen O, Holst B, Grarup N, Schwartz TW, Hansen T. Functional and genetic epidemiological characterisation of the FFAR4 (GPR120) p.R270H variant in the Danish population. J Med Genet 2016;53:616-23. [PMID: 27068006 DOI: 10.1136/jmedgenet-2015-103728] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
325 Dijksterhuis JP, Petersen J, Schulte G. WNT/Frizzled signalling: receptor-ligand selectivity with focus on FZD-G protein signalling and its physiological relevance: IUPHAR Review 3. Br J Pharmacol. 2014;171:1195-1209. [PMID: 24032637 DOI: 10.1111/bph.12364] [Cited by in Crossref: 119] [Cited by in F6Publishing: 116] [Article Influence: 14.9] [Reference Citation Analysis]
326 Bondarenko AI. Endothelial atypical cannabinoid receptor: do we have enough evidence? Br J Pharmacol 2014;171:5573-88. [PMID: 25073723 DOI: 10.1111/bph.12866] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
327 Pechánová O, Varga ZV, Cebová M, Giricz Z, Pacher P, Ferdinandy P. Cardiac NO signalling in the metabolic syndrome. Br J Pharmacol 2015;172:1415-33. [PMID: 25297560 DOI: 10.1111/bph.12960] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
328 Cosentino M, Marino F, Maestroni GJ. Sympathoadrenergic modulation of hematopoiesis: a review of available evidence and of therapeutic perspectives. Front Cell Neurosci 2015;9:302. [PMID: 26300737 DOI: 10.3389/fncel.2015.00302] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
329 Hyland NP, Golubeva AV. GABAB receptors in the bladder and bowel: therapeutic potential for positive allosteric modulators?: Commentary on Kalinichev et al., Br J Pharmacol 171: 995-1006. Br J Pharmacol 2015;172:4588-90. [PMID: 24641323 DOI: 10.1111/bph.12617] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
330 Schmeltzer SN, Herman JP, Sah R. Neuropeptide Y (NPY) and posttraumatic stress disorder (PTSD): A translational update. Exp Neurol 2016;284:196-210. [PMID: 27377319 DOI: 10.1016/j.expneurol.2016.06.020] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 7.3] [Reference Citation Analysis]
331 Hofmann NA, Yang J, Trauger SA, Nakayama H, Huang L, Strunk D, Moses MA, Klagsbrun M, Bischoff J, Graier WF. The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis. Br J Pharmacol 2015;172:4107-18. [PMID: 25989290 DOI: 10.1111/bph.13196] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
332 Feliú A, Moreno-Martet M, Mecha M, Carrillo-Salinas FJ, de Lago E, Fernández-Ruiz J, Guaza C. A Sativex(®) -like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis. Br J Pharmacol 2015;172:3579-95. [PMID: 25857324 DOI: 10.1111/bph.13159] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
333 Kleinbongard P, Gedik N, Witting P, Freedman B, Klöcker N, Heusch G. Pleiotropic, heart rate-independent cardioprotection by ivabradine. Br J Pharmacol 2015;172:4380-90. [PMID: 26076181 DOI: 10.1111/bph.13220] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 6.4] [Reference Citation Analysis]
334 Pabreja K, Mohd MA, Koole C, Wootten D, Furness SG. Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP-1R activation. Br J Pharmacol 2014;171:1114-28. [PMID: 23889512 DOI: 10.1111/bph.12313] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
335 Leach K, Sexton PM, Christopoulos A, Conigrave AD. Engendering biased signalling from the calcium-sensing receptor for the pharmacotherapy of diverse disorders. Br J Pharmacol. 2014;171:1142-1155. [PMID: 24111791 DOI: 10.1111/bph.12420] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
336 Petri D, Schlicker E. A search for presynaptic inhibitory histamine receptors in guinea-pig tissues: Further H3 receptors but no evidence for H4 receptors. Neuropharmacology 2016;106:129-34. [PMID: 26211976 DOI: 10.1016/j.neuropharm.2015.06.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
337 Congreve M, Doré AS, Jazayeri A, Nonoo R. Engineering G Protein-Coupled Receptors for Drug Design. In: Scapin G, Patel D, Arnold E, editors. Multifaceted Roles of Crystallography in Modern Drug Discovery. Dordrecht: Springer Netherlands; 2015. pp. 1-18. [DOI: 10.1007/978-94-017-9719-1_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
338 Ginsburg BC, Lamb RJ. Drug effects on multiple and concurrent schedules of ethanol- and food-maintained behaviour: context-dependent selectivity. Br J Pharmacol 2014;171:3499-510. [PMID: 24697498 DOI: 10.1111/bph.12707] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
339 Avraham HK, Jiang S, Fu Y, Rockenstein E, Makriyannis A, Wood J, Wang L, Masliah E, Avraham S. Impaired neurogenesis by HIV-1-Gp120 is rescued by genetic deletion of fatty acid amide hydrolase enzyme. Br J Pharmacol 2015;172:4603-14. [PMID: 24571443 DOI: 10.1111/bph.12657] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
340 Wang XQ, Ma J, Cui W, Yuan WX, Zhu G, Yang Q, Heng LJ, Gao GD. The endocannabinoid system regulates synaptic transmission in nucleus accumbens by increasing DAGL-α expression following short-term morphine withdrawal. Br J Pharmacol 2016;173:1143-53. [PMID: 25296881 DOI: 10.1111/bph.12969] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
341 Rosa M, Bech-Serra JJ, Canals F, Zajac JM, Talmont F, Arsequell G, Valencia G. Optimized Proteomic Mass Spectrometry Characterization of Recombinant Human μ-Opioid Receptor Functionally Expressed in Pichia pastoris Cell Lines. J Proteome Res 2015;14:3162-73. [PMID: 26090583 DOI: 10.1021/acs.jproteome.5b00104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
342 Zhang XJ, Jiang DS, Li H. The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases. Br J Pharmacol 2015;172:5457-76. [PMID: 25131895 DOI: 10.1111/bph.12881] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
343 Downer EJ. High hopes for CB(2) receptors in neurogenesis. Br J Pharmacol 2014;171:1345-6. [PMID: 24321050 DOI: 10.1111/bph.12548] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
344 Yamamoto K, Asano K, Tasaka A, Ogura Y, Kim S, Ito Y, Yamatodani A. Involvement of substance P in the development of cisplatin-induced acute and delayed pica in rats. Br J Pharmacol 2014;171:2888-99. [PMID: 24641692 DOI: 10.1111/bph.12629] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
345 Sasaki K, Sumiyoshi A, Nonaka H, Kasahara Y, Ikeda K, Hall FS, Uhl GR, Watanabe M, Kawashima R, Sora I. Specific regions display altered grey matter volume in μ-opioid receptor knockout mice: MRI voxel-based morphometry. Br J Pharmacol 2015;172:654-67. [PMID: 24913308 DOI: 10.1111/bph.12807] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
346 Tian C, Shao CH, Padanilam C, Ezell E, Singh J, Kutty S, Bidasee KR. CCDI: a new ligand that modulates mammalian type 1 ryanodine receptor (RyR1). Br J Pharmacol 2014;171:4097-111. [PMID: 24819467 DOI: 10.1111/bph.12764] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
347 Bond RA, Thanawala VJ, Parra S, Leff P. Differences in asthma study models and the effectiveness of β2 -adrenoceptor ligands: response to Lipworth et al. Br J Pharmacol 2016;173:250-1. [PMID: 26687674 DOI: 10.1111/bph.13334] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
348 Nisar SP, Jones ML, Cunningham MR, Mumford AD, Mundell SJ; UK GAPP Study Group. Rare platelet GPCR variants: what can we learn? Br J Pharmacol 2015;172:3242-53. [PMID: 25231155 DOI: 10.1111/bph.12941] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
349 Komarnytsky S, Rathinasabapathy T, Wagner C, Metzger B, Carlisle C, Panda C, Le Brun-Blashka S, Troup JP, Varadharaj S. Endocannabinoid System and Its Regulation by Polyunsaturated Fatty Acids and Full Spectrum Hemp Oils. Int J Mol Sci 2021;22:5479. [PMID: 34067450 DOI: 10.3390/ijms22115479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
350 Iijima M, Yoshimizu T, Shimazaki T, Tokugawa K, Fukumoto K, Kurosu S, Kuwada T, Sekiguchi Y, Chaki S. Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325. Br J Pharmacol 2014;171:3511-25. [PMID: 24654684 DOI: 10.1111/bph.12699] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 5.1] [Reference Citation Analysis]
351 Brütting C, Emmer A, Kornhuber M, Staege MS. A survey of endogenous retrovirus (ERV) sequences in the vicinity of multiple sclerosis (MS)-associated single nucleotide polymorphisms (SNPs). Mol Biol Rep 2016;43:827-36. [PMID: 27169423 DOI: 10.1007/s11033-016-4004-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
352 Sampson AK, Irvine JC, Shihata WA, Dragoljevic D, Lumsden N, Huet O, Barnes T, Unger T, Steckelings UM, Jennings GL, Widdop RE, Chin-Dusting JP. Compound 21, a selective agonist of angiotensin AT2 receptors, prevents endothelial inflammation and leukocyte adhesion in vitro and in vivo. Br J Pharmacol 2016;173:729-40. [PMID: 25560767 DOI: 10.1111/bph.13063] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 5.4] [Reference Citation Analysis]
353 Wang J, An L, Zhao Y, Zhang C, Li S, Ye C, Jing S, Hang H. In vitro affinity maturation of antibody against membrane-bound GPCR molecules. Appl Microbiol Biotechnol 2019;103:7703-17. [PMID: 31359103 DOI: 10.1007/s00253-019-10030-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
354 Chiang T, Sansuk K, van Rijn RM. β-Arrestin 2 dependence of δ opioid receptor agonists is correlated with alcohol intake. Br J Pharmacol 2016;173:332-43. [PMID: 26507558 DOI: 10.1111/bph.13374] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 6.2] [Reference Citation Analysis]
355 Sarwar M, Samuel CS, Bathgate RA, Stewart DR, Summers RJ. Serelaxin-mediated signal transduction in human vascular cells: bell-shaped concentration-response curves reflect differential coupling to G proteins. Br J Pharmacol. 2015;172:1005-1019. [PMID: 25297987 DOI: 10.1111/bph.12964] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 6.4] [Reference Citation Analysis]
356 Nicole P, Couvineau P, Jamin N, Voisin T, Couvineau A. Crucial role of the orexin-B C-terminus in the induction of OX1 receptor-mediated apoptosis: analysis by alanine scanning, molecular modelling and site-directed mutagenesis. Br J Pharmacol 2015;172:5211-23. [PMID: 26282891 DOI: 10.1111/bph.13287] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
357 Pisarenko O, Shulzhenko V, Studneva I, Pelogeykina Y, Timoshin A, Anesia R, Valet P, Parini A, Kunduzova O. Structural apelin analogues: mitochondrial ROS inhibition and cardiometabolic protection in myocardial ischaemia reperfusion injury. Br J Pharmacol 2015;172:2933-45. [PMID: 25521429 DOI: 10.1111/bph.13038] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
358 Reichmann F, Holzer P. Neuropeptide Y: A stressful review. Neuropeptides. 2016;55:99-109. [PMID: 26441327 DOI: 10.1016/j.npep.2015.09.008] [Cited by in Crossref: 188] [Cited by in F6Publishing: 177] [Article Influence: 26.9] [Reference Citation Analysis]
359 Johnson AC, Greenwood-Van Meerveld B. Stress-induced pain: a target for the development of novel therapeutics. J Pharmacol Exp Ther 2014;351:327-35. [PMID: 25194019 DOI: 10.1124/jpet.114.218065] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
360 Maftei D, Marconi V, Florenzano F, Giancotti LA, Castelli M, Moretti S, Borsani E, Rodella LF, Balboni G, Luongo L, Maione S, Sacerdote P, Negri L, Lattanzi R. Controlling the activation of the Bv8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals. Br J Pharmacol 2014;171:4850-65. [PMID: 24902717 DOI: 10.1111/bph.12793] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
361 Steen A, Sparre-Ulrich AH, Thiele S, Guo D, Frimurer TM, Rosenkilde MM. Gating function of isoleucine-116 in TM-3 (position III:16/3.40) for the activity state of the CC-chemokine receptor 5 (CCR5). Br J Pharmacol 2014;171:1566-79. [PMID: 24328926 DOI: 10.1111/bph.12553] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
362 Peters E, Geraci S, Heemskerk S, Wilmer MJ, Bilos A, Kraenzlin B, Gretz N, Pickkers P, Masereeuw R. Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate. Br J Pharmacol 2015;172:4932-45. [PMID: 26222228 DOI: 10.1111/bph.13261] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 5.6] [Reference Citation Analysis]
363 Ludeman JP, Stone MJ. The structural role of receptor tyrosine sulfation in chemokine recognition. Br J Pharmacol 2014;171:1167-79. [PMID: 24116930 DOI: 10.1111/bph.12455] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 9.3] [Reference Citation Analysis]
364 Hsu CK, Lin CC, Hsiao LD, Yang CM. Mevastatin ameliorates sphingosine 1-phosphate-induced COX-2/PGE2-dependent cell migration via FoxO1 and CREB phosphorylation and translocation. Br J Pharmacol 2015;172:5360-76. [PMID: 26359950 DOI: 10.1111/bph.13326] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
365 Dux M, Will C, Vogler B, Filipovic MR, Messlinger K. Meningeal blood flow is controlled by H2 S-NO crosstalk activating a HNO-TRPA1-CGRP signalling pathway. Br J Pharmacol 2016;173:431-45. [PMID: 25884403 DOI: 10.1111/bph.13164] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
366 Altmann JB, Yan G, Meeks JF, Abood ME, Brailoiu E, Brailoiu GC. G protein-coupled estrogen receptor-mediated effects on cytosolic calcium and nanomechanics in brain microvascular endothelial cells. J Neurochem 2015;133:629-39. [PMID: 25703621 DOI: 10.1111/jnc.13066] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
367 Weston C, Poyner D, Patel V, Dowell S, Ladds G. Investigating G protein signalling bias at the glucagon-like peptide-1 receptor in yeast. Br J Pharmacol 2014;171:3651-65. [PMID: 24712679 DOI: 10.1111/bph.12716] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
368 Gobbetti T, Ducheix S, le Faouder P, Perez T, Riols F, Boue J, Bertrand-Michel J, Dubourdeau M, Guillou H, Perretti M, Vergnolle N, Cenac N. Protective effects of n-6 fatty acids-enriched diet on intestinal ischaemia/reperfusion injury involve lipoxin A4 and its receptor. Br J Pharmacol 2015;172:910-23. [PMID: 25296998 DOI: 10.1111/bph.12957] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
369 Granholm L, Roman E, Nylander I. Single housing during early adolescence causes time-, area- and peptide-specific alterations in endogenous opioids of rat brain. Br J Pharmacol 2015;172:606-14. [PMID: 24821004 DOI: 10.1111/bph.12753] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
370 Ong EW, Xue L, Olmstead MC, Cahill CM. Prolonged morphine treatment alters δ opioid receptor post-internalization trafficking. Br J Pharmacol 2015;172:615-29. [PMID: 24819092 DOI: 10.1111/bph.12761] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
371 Nassini R, Fusi C, Materazzi S, Coppi E, Tuccinardi T, Marone IM, De Logu F, Preti D, Tonello R, Chiarugi A, Patacchini R, Geppetti P, Benemei S. The TRPA1 channel mediates the analgesic action of dipyrone and pyrazolone derivatives. Br J Pharmacol 2015;172:3397-411. [PMID: 25765567 DOI: 10.1111/bph.13129] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 6.9] [Reference Citation Analysis]
372 Cross AJ, Widzowski D, Maciag C, Zacco A, Hudzik T, Liu J, Nyberg S, Wood MW. Quetiapine and its metabolite norquetiapine: translation from in vitro pharmacology to in vivo efficacy in rodent models. Br J Pharmacol 2016;173:155-66. [PMID: 26436896 DOI: 10.1111/bph.13346] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
373 Lanzerstorfer P, Stadlbauer V, Chtcheglova LA, Haselgrübler R, Borgmann D, Wruss J, Hinterdorfer P, Schröder K, Winkler SM, Höglinger O, Weghuber J. Identification of novel insulin mimetic drugs by quantitative total internal reflection fluorescence (TIRF) microscopy. Br J Pharmacol 2014;171:5237-51. [PMID: 25039620 DOI: 10.1111/bph.12845] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
374 Graham DL, Buendia MA, Chapman MA, Durai HH, Stanwood GD. Deletion of Gαq in the telencephalon alters specific neurobehavioral outcomes. Synapse 2015;69:434-45. [PMID: 25963901 DOI: 10.1002/syn.21830] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
375 Mihara K, Ramachandran R, Saifeddine M, Hansen KK, Renaux B, Polley D, Gibson S, Vanderboor C, Hollenberg MD. Thrombin-Mediated Direct Activation of Proteinase-Activated Receptor-2: Another Target for Thrombin Signaling. Mol Pharmacol 2016;89:606-14. [PMID: 26957205 DOI: 10.1124/mol.115.102723] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 8.0] [Reference Citation Analysis]
376 Reiss C, Mindukshev I, Bischoff V, Subramanian H, Kehrer L, Friebe A, Stasch JP, Gambaryan S, Walter U. The sGC stimulator riociguat inhibits platelet function in washed platelets but not in whole blood. Br J Pharmacol 2015;172:5199-210. [PMID: 26282717 DOI: 10.1111/bph.13286] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
377 Neveu C, Dulin F, Lefranc B, Galas L, Calbrix C, Bureau R, Rault S, Chuquet J, Boutin JA, Guilhaudis L, Ségalas-Milazzo I, Vaudry D, Vaudry H, Santos JS, Leprince J. Molecular basis of agonist docking in a human GPR103 homology model by site-directed mutagenesis and structure-activity relationship studies. Br J Pharmacol 2014;171:4425-39. [PMID: 24913445 DOI: 10.1111/bph.12808] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
378 Schmidt MR, Redington A, Bøtker HE. Remote conditioning the heart overview: translatability and mechanism. Br J Pharmacol 2015;172:1947-60. [PMID: 25219984 DOI: 10.1111/bph.12933] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
379 Helmy MW, El-Gowelli HM, Ali RM, El-Mas MM. Endothelin ETA receptor/lipid peroxides/COX-2/TGF-β1 signalling underlies aggravated nephrotoxicity caused by cyclosporine plus indomethacin in rats. Br J Pharmacol 2015;172:4291-302. [PMID: 26013701 DOI: 10.1111/bph.13199] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
380 Yoshiki H, Uwada J, Anisuzzaman AS, Umada H, Hayashi R, Kainoh M, Masuoka T, Nishio M, Muramatsu I. Pharmacologically distinct phenotypes of α1B -adrenoceptors: variation in binding and functional affinities for antagonists. Br J Pharmacol 2014;171:4890-901. [PMID: 24923551 DOI: 10.1111/bph.12813] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
381 Khalaf HM, Abdalla AM, Ahmed AF, Abdel-aziz AM. Role of nitric oxide in mediating the cardioprotective effect of agomelatine against isoproterenol-induced myocardial injury in rats. Naunyn-Schmiedeberg's Arch Pharmacol 2020;393:1809-23. [DOI: 10.1007/s00210-020-01860-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
382 Reinecke H, Weber C, Lange K, Simon M, Stein C, Sorgatz H. Analgesic efficacy of opioids in chronic pain: recent meta-analyses. Br J Pharmacol 2015;172:324-33. [PMID: 24640991 DOI: 10.1111/bph.12634] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 7.3] [Reference Citation Analysis]
383 Noble F, Lenoir M, Marie N. The opioid receptors as targets for drug abuse medication. Br J Pharmacol 2015;172:3964-79. [PMID: 25988826 DOI: 10.1111/bph.13190] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
384 Citraro R, Leo A, De Fazio P, De Sarro G, Russo E. Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy. Br J Pharmacol 2015;172:3177-88. [PMID: 25754610 DOI: 10.1111/bph.13121] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 5.4] [Reference Citation Analysis]
385 Bahari Z, Meftahi GH. Spinal α2 -adrenoceptors and neuropathic pain modulation; therapeutic target. Br J Pharmacol 2019;176:2366-81. [PMID: 30657594 DOI: 10.1111/bph.14580] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
386 Johnson AC, Greenwood-Van Meerveld B. The Pharmacology of Visceral Pain. Adv Pharmacol 2016;75:273-301. [PMID: 26920016 DOI: 10.1016/bs.apha.2015.11.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
387 Ding H, Hayashida K, Suto T, Sukhtankar DD, Kimura M, Mendenhall V, Ko MC. Supraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primates. Br J Pharmacol 2015;172:3302-12. [PMID: 25752320 DOI: 10.1111/bph.13124] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
388 Stoddart LA, White CW, Nguyen K, Hill SJ, Pfleger KD. Fluorescence- and bioluminescence-based approaches to study GPCR ligand binding. Br J Pharmacol 2016;173:3028-37. [PMID: 26317175 DOI: 10.1111/bph.13316] [Cited by in Crossref: 66] [Cited by in F6Publishing: 65] [Article Influence: 9.4] [Reference Citation Analysis]
389 Nielsen N, Lindemann O, Schwab A. TRP channels and STIM/ORAI proteins: sensors and effectors of cancer and stroma cell migration. Br J Pharmacol 2014;171:5524-40. [PMID: 24724725 DOI: 10.1111/bph.12721] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
390 Zoppi S, Madrigal JL, Caso JR, García-Gutiérrez MS, Manzanares J, Leza JC, García-Bueno B. Regulatory role of the cannabinoid CB2 receptor in stress-induced neuroinflammation in mice. Br J Pharmacol 2014;171:2814-26. [PMID: 24467609 DOI: 10.1111/bph.12607] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 5.8] [Reference Citation Analysis]
391 Joshi T, Johnson M, Newton R, Giembycz MA. The long-acting β2 -adrenoceptor agonist, indacaterol, enhances glucocorticoid receptor-mediated transcription in human airway epithelial cells in a gene- and agonist-dependent manner. Br J Pharmacol 2015;172:2634-53. [PMID: 25598440 DOI: 10.1111/bph.13087] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
392 Bozinovski S, Vlahos R, Anthony D, McQualter J, Anderson G, Irving L, Steinfort D. COPD and squamous cell lung cancer: aberrant inflammation and immunity is the common link. Br J Pharmacol 2016;173:635-48. [PMID: 26013585 DOI: 10.1111/bph.13198] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 7.9] [Reference Citation Analysis]
393 Klenowski P, Morgan M, Bartlett SE. The role of δ-opioid receptors in learning and memory underlying the development of addiction. Br J Pharmacol 2015;172:297-310. [PMID: 24641428 DOI: 10.1111/bph.12618] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
394 Snelder N, Ploeger BA, Luttringer O, Rigel DF, Fu F, Beil M, Stanski DR, Danhof M. Drug effects on the CVS in conscious rats: separating cardiac output into heart rate and stroke volume using PKPD modelling. Br J Pharmacol 2014;171:5076-92. [PMID: 24962208 DOI: 10.1111/bph.12824] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
395 Snijder PM, Frenay AR, de Boer RA, Pasch A, Hillebrands JL, Leuvenink HG, van Goor H. Exogenous administration of thiosulfate, a donor of hydrogen sulfide, attenuates angiotensin II-induced hypertensive heart disease in rats. Br J Pharmacol 2015;172:1494-504. [PMID: 24962324 DOI: 10.1111/bph.12825] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 9.3] [Reference Citation Analysis]
396 Bauer J, Ripperger A, Frantz S, Ergün S, Schwedhelm E, Benndorf RA. Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation. Br J Pharmacol 2014;171:3115-31. [PMID: 24646155 DOI: 10.1111/bph.12677] [Cited by in Crossref: 82] [Cited by in F6Publishing: 76] [Article Influence: 11.7] [Reference Citation Analysis]
397 Morgat C, Mishra AK, Varshney R, Allard M, Fernandez P, Hindié E. Targeting neuropeptide receptors for cancer imaging and therapy: perspectives with bombesin, neurotensin, and neuropeptide-Y receptors. J Nucl Med 2014;55:1650-7. [PMID: 25189338 DOI: 10.2967/jnumed.114.142000] [Cited by in Crossref: 71] [Cited by in F6Publishing: 63] [Article Influence: 8.9] [Reference Citation Analysis]
398 Mukhopadhyay P, Baggelaar M, Erdelyi K, Cao Z, Cinar R, Fezza F, Ignatowska-Janlowska B, Wilkerson J, van Gils N, Hansen T, Ruben M, Soethoudt M, Heitman L, Kunos G, Maccarrone M, Lichtman A, Pacher P, Van der Stelt M. The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity. Br J Pharmacol 2016;173:446-58. [PMID: 26398481 DOI: 10.1111/bph.13338] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
399 Schilling JM, Roth DM, Patel HH. Caveolins in cardioprotection - translatability and mechanisms. Br J Pharmacol 2015;172:2114-25. [PMID: 25377989 DOI: 10.1111/bph.13009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
400 Hoehlig K, Johnson KW, Pryazhnikov E, Maasch C, Clemens-Smith A, Purschke WG, Vauléon S, Buchner K, Jarosch F, Khiroug L, Vater A, Klussmann S. A novel CGRP-neutralizing Spiegelmer attenuates neurogenic plasma protein extravasation. Br J Pharmacol 2015;172:3086-98. [PMID: 25659966 DOI: 10.1111/bph.13110] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
401 Shukla P, Rao GM, Pandey G, Sharma S, Mittapelly N, Shegokar R, Mishra PR. Therapeutic interventions in sepsis: current and anticipated pharmacological agents. Br J Pharmacol 2014;171:5011-31. [PMID: 24977655 DOI: 10.1111/bph.12829] [Cited by in Crossref: 9] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
402 Takahashi K, Kitamura N, Suzuki Y, Yamanaka Y, Shinohara H, Shibuya I. Activation of muscarinic acetylcholine receptors elevates intracellular Ca(2+) concentrations in accessory lobe neurons of the chick. J Comp Physiol A Neuroethol Sens Neural Behav Physiol 2015;201:385-94. [PMID: 25481714 DOI: 10.1007/s00359-014-0971-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
403 Zemdegs J, Quesseveur G, Jarriault D, Pénicaud L, Fioramonti X, Guiard BP. High-fat diet-induced metabolic disorders impairs 5-HT function and anxiety-like behavior in mice. Br J Pharmacol 2016;173:2095-110. [PMID: 26472268 DOI: 10.1111/bph.13343] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 10.3] [Reference Citation Analysis]
404 Laurino A, De Siena G, Resta F, Masi A, Musilli C, Zucchi R, Raimondi L. 3-iodothyroacetic acid, a metabolite of thyroid hormone, induces itch and reduces threshold to noxious and to painful heat stimuli in mice. Br J Pharmacol 2015;172:1859-68. [PMID: 25439265 DOI: 10.1111/bph.13032] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
405 Han J, Sun L, Huang X, Li Z, Zhang C, Qian H, Huang W. Novel coumarin modified GLP-1 derivatives with enhanced plasma stability and prolonged in vivo glucose-lowering ability. Br J Pharmacol 2014;171:5252-64. [PMID: 25039358 DOI: 10.1111/bph.12843] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
406 Hoefig CS, Jacobi SF, Warner A, Harder L, Schanze N, Vennström B, Mittag J. 3-Iodothyroacetic acid lacks thermoregulatory and cardiovascular effects in vivo. Br J Pharmacol 2015;172:3426-33. [PMID: 25765843 DOI: 10.1111/bph.13131] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
407 Wood M, Dubois V, Scheller D, Gillard M. Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors. Br J Pharmacol 2015;172:1124-35. [PMID: 25339241 DOI: 10.1111/bph.12988] [Cited by in Crossref: 54] [Cited by in F6Publishing: 41] [Article Influence: 7.7] [Reference Citation Analysis]
408 Balenga NA, Martínez-Pinilla E, Kargl J, Schröder R, Peinhaupt M, Platzer W, Bálint Z, Zamarbide M, Dopeso-Reyes IG, Ricobaraza A, Pérez-Ortiz JM, Kostenis E, Waldhoer M, Heinemann A, Franco R. Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling. Br J Pharmacol 2014;171:5387-406. [PMID: 25048571 DOI: 10.1111/bph.12850] [Cited by in Crossref: 77] [Cited by in F6Publishing: 69] [Article Influence: 9.6] [Reference Citation Analysis]
409 Kocan M, Sarwar M, Hossain MA, Wade JD, Summers RJ. Signalling profiles of H3 relaxin, H2 relaxin and R3(BΔ23-27)R/I5 acting at the relaxin family peptide receptor 3 (RXFP3). Br J Pharmacol 2014;171:2827-41. [PMID: 24641548 DOI: 10.1111/bph.12623] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
410 Rao R, Nagarkatti PS, Nagarkatti M. Δ(9) Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells. Br J Pharmacol 2015;172:1792-806. [PMID: 25425209 DOI: 10.1111/bph.13026] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 4.3] [Reference Citation Analysis]
411 Wang X, Ji Y, Yang B. Chinese innovation in cardiovascular drug discovery. Br J Pharmacol 2015;172:5425-9. [PMID: 26629875 DOI: 10.1111/bph.13363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
412 Tamargo J, Caballero R, Delpón E. The Renin–Angiotensin System and Bone. Clinic Rev Bone Miner Metab 2015;13:125-48. [DOI: 10.1007/s12018-015-9189-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
413 Smith NJ. Drug Discovery Opportunities at the Endothelin B Receptor-Related Orphan G Protein-Coupled Receptors, GPR37 and GPR37L1. Front Pharmacol 2015;6:275. [PMID: 26635605 DOI: 10.3389/fphar.2015.00275] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
414 Orstavik O, Ata SH, Riise J, Dahl CP, Andersen GØ, Levy FO, Skomedal T, Osnes JB, Qvigstad E. Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart. Br J Pharmacol 2014;171:5169-81. [PMID: 24547784 DOI: 10.1111/bph.12647] [Cited by in Crossref: 42] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
415 Cascio MG, Zamberletti E, Marini P, Parolaro D, Pertwee RG. The phytocannabinoid, Δ⁹-tetrahydrocannabivarin, can act through 5-HT₁A receptors to produce antipsychotic effects. Br J Pharmacol 2015;172:1305-18. [PMID: 25363799 DOI: 10.1111/bph.13000] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
416 Capasso R, Orlando P, Pagano E, Aveta T, Buono L, Borrelli F, Di Marzo V, Izzo AA. Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1 channels. Br J Pharmacol. 2014;171:4026-4037. [PMID: 24818658 DOI: 10.1111/bph.12759] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 7.7] [Reference Citation Analysis]
417 Pačesová D, Volfová B, Červená K, Hejnová L, Novotný J, Bendová Z. Acute morphine affects the rat circadian clock via rhythms of phosphorylated ERK1/2 and GSK3β kinases and Per1 expression in the rat suprachiasmatic nucleus. Br J Pharmacol 2015;172:3638-49. [PMID: 25828914 DOI: 10.1111/bph.13152] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
418 Bortolato A, Doré AS, Hollenstein K, Tehan BG, Mason JS, Marshall FH. Structure of Class B GPCRs: new horizons for drug discovery. Br J Pharmacol 2014;171:3132-45. [PMID: 24628305 DOI: 10.1111/bph.12689] [Cited by in Crossref: 75] [Cited by in F6Publishing: 62] [Article Influence: 10.7] [Reference Citation Analysis]
419 Garland CJ, Smirnov SV, Bagher P, Lim CS, Huang CY, Mitchell R, Stanley C, Pinkney A, Dora KA. TRPM4 inhibitor 9-phenanthrol activates endothelial cell intermediate conductance calcium-activated potassium channels in rat isolated mesenteric artery. Br J Pharmacol 2015;172:1114-23. [PMID: 25323322 DOI: 10.1111/bph.12985] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
420 Morioka N, Suekama K, Zhang FF, Kajitani N, Hisaoka-Nakashima K, Takebayashi M, Nakata Y. Amitriptyline up-regulates connexin43-gap junction in rat cultured cortical astrocytes via activation of the p38 and c-Fos/AP-1 signalling pathway. Br J Pharmacol 2014;171:2854-67. [PMID: 24641259 DOI: 10.1111/bph.12614] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 5.3] [Reference Citation Analysis]
421 Kleinbongard P, Heusch G. Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection? Br J Pharmacol 2015;172:2010-25. [PMID: 25204973 DOI: 10.1111/bph.12902] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 6.4] [Reference Citation Analysis]
422 AlSuleimani YM, Hiley CR. The GPR55 agonist lysophosphatidylinositol relaxes rat mesenteric resistance artery and induces Ca(2+) release in rat mesenteric artery endothelial cells. Br J Pharmacol 2015;172:3043-57. [PMID: 25652040 DOI: 10.1111/bph.13107] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
423 Slowik A, Schmidt T, Beyer C, Amor S, Clarner T, Kipp M. The sphingosine 1-phosphate receptor agonist FTY720 is neuroprotective after cuprizone-induced CNS demyelination. Br J Pharmacol 2015;172:80-92. [PMID: 25220526 DOI: 10.1111/bph.12938] [Cited by in Crossref: 65] [Cited by in F6Publishing: 70] [Article Influence: 8.1] [Reference Citation Analysis]
424 Gurevich EV, Gurevich VV. Beyond traditional pharmacology: new tools and approaches. Br J Pharmacol. 2015;172:3229-3241. [PMID: 25572005 DOI: 10.1111/bph.13066] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
425 Paci M, Hyttinen J, Rodriguez B, Severi S. Human induced pluripotent stem cell-derived versus adult cardiomyocytes: an in silico electrophysiological study on effects of ionic current block. Br J Pharmacol 2015;172:5147-60. [PMID: 26276951 DOI: 10.1111/bph.13282] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 5.7] [Reference Citation Analysis]
426 Lee MC, Yang YC, Chen YC, Chang BS, Li YC, Huang SC. Estrogen and G protein-coupled estrogen receptor agonist G-1 cause relaxation of human gallbladder. Ci Ji Yi Xue Za Zhi 2016;28:54-8. [PMID: 28757722 DOI: 10.1016/j.tcmj.2016.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
427 Clemmensen C, Smajilovic S, Wellendorph P, Bräuner-Osborne H. The GPCR, class C, group 6, subtype A (GPRC6A) receptor: from cloning to physiological function. Br J Pharmacol 2014;171:1129-41. [PMID: 24032653 DOI: 10.1111/bph.12365] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 8.0] [Reference Citation Analysis]
428 Cross MJ, Berridge BR, Clements PJ, Cove-Smith L, Force TL, Hoffmann P, Holbrook M, Lyon AR, Mellor HR, Norris AA, Pirmohamed M, Tugwood JD, Sidaway JE, Park BK. Physiological, pharmacological and toxicological considerations of drug-induced structural cardiac injury. Br J Pharmacol 2015;172:957-74. [PMID: 25302413 DOI: 10.1111/bph.12979] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 6.6] [Reference Citation Analysis]
429 Beaulieu JM, Espinoza S, Gainetdinov RR. Dopamine receptors - IUPHAR Review 13. Br J Pharmacol 2015;172:1-23. [PMID: 25671228 DOI: 10.1111/bph.12906] [Cited by in Crossref: 250] [Cited by in F6Publishing: 215] [Article Influence: 35.7] [Reference Citation Analysis]
430 Knapman A, Connor M. Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1). Br J Pharmacol 2015;172:349-63. [PMID: 24527749 DOI: 10.1111/bph.12644] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
431 Gastaldi S, Zamboni M, Bolasco G, Di Segni G, Tocchini-Valentini GP. Analysis of random PCR-originated mutants of the yeast Ste2 and Ste3 receptors. Microbiologyopen 2016;5:670-86. [PMID: 27150158 DOI: 10.1002/mbo3.361] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
432 Gregg RA, Baumann MH, Partilla JS, Bonano JS, Vouga A, Tallarida CS, Velvadapu V, Smith GR, Peet MM, Reitz AB, Negus SS, Rawls SM. Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in rats. Br J Pharmacol 2015;172:883-94. [PMID: 25255824 DOI: 10.1111/bph.12951] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 6.5] [Reference Citation Analysis]
433 Gendron L, Mittal N, Beaudry H, Walwyn W. Recent advances on the δ opioid receptor: from trafficking to function. Br J Pharmacol 2015;172:403-19. [PMID: 24665909 DOI: 10.1111/bph.12706] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 6.5] [Reference Citation Analysis]
434 He X, Zhao M, Bi X, Sun L, Yu X, Zhao M, Zang W. Novel strategies and underlying protective mechanisms of modulation of vagal activity in cardiovascular diseases. Br J Pharmacol 2015;172:5489-500. [PMID: 25378088 DOI: 10.1111/bph.13010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 5.4] [Reference Citation Analysis]
435 Magalhães GS, Rodrigues-Machado MG, Motta-Santos D, Silva AR, Caliari MV, Prata LO, Abreu SC, Rocco PR, Barcelos LS, Santos RA, Campagnole-Santos MJ. Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation. Br J Pharmacol 2015;172:2330-42. [PMID: 25559763 DOI: 10.1111/bph.13057] [Cited by in Crossref: 59] [Cited by in F6Publishing: 54] [Article Influence: 8.4] [Reference Citation Analysis]
436 Gore A, Bloch-Shilderman E, Egoz I, Turetz J, Brandeis R. Efficacy assessment of a combined anticholinergic and oxime treatment against topical sarin-induced miosis and visual impairment in rats. Br J Pharmacol 2014;171:2364-74. [PMID: 24428128 DOI: 10.1111/bph.12586] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
437 Ayanwuyi LO, Stopponi S, Ubaldi M, Cippitelli A, Nasuti C, Damadzic R, Heilig M, Schank J, Cheng K, Rice KC, Ciccocioppo R. Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in Wistar rats. Br J Pharmacol 2015;172:5136-46. [PMID: 26275374 DOI: 10.1111/bph.13280] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
438 Dosa PI, Amin EA. Tactical Approaches to Interconverting GPCR Agonists and Antagonists. J Med Chem 2016;59:810-40. [PMID: 26390077 DOI: 10.1021/acs.jmedchem.5b00982] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
439 Zhou J, Luo Y, Zhang JT, Li MX, Wang CM, Guan XL, Wu PF, Hu ZL, Jin Y, Ni L, Wang F, Chen JG. Propranolol decreases retention of fear memory by modulating the stability of surface glutamate receptor GluA1 subunits in the lateral amygdala. Br J Pharmacol 2015;172:5068-82. [PMID: 26228348 DOI: 10.1111/bph.13272] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
440 Nederpelt I, Georgi V, Schiele F, Nowak-Reppel K, Fernández-Montalván AE, IJzerman AP, Heitman LH. Characterization of 12 GnRH peptide agonists - a kinetic perspective. Br J Pharmacol 2016;173:128-41. [PMID: 26398856 DOI: 10.1111/bph.13342] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
441 Putula J, Pihlajamaa T, Kukkonen JP. Calcium affects OX1 orexin (hypocretin) receptor responses by modifying both orexin binding and the signal transduction machinery. Br J Pharmacol 2014;171:5816-28. [PMID: 25132134 DOI: 10.1111/bph.12883] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
442 Ferreira SG, Gonçalves FQ, Marques JM, Tomé ÂR, Rodrigues RJ, Nunes-Correia I, Ledent C, Harkany T, Venance L, Cunha RA, Köfalvi A. Presynaptic adenosine A2A receptors dampen cannabinoid CB1 receptor-mediated inhibition of corticostriatal glutamatergic transmission. Br J Pharmacol 2015;172:1074-86. [PMID: 25296982 DOI: 10.1111/bph.12970] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
443 Matsumoto T, Goulopoulou S, Taguchi K, Tostes RC, Kobayashi T. Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. Br J Pharmacol 2015;172:3980-4001. [PMID: 26031319 DOI: 10.1111/bph.13205] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
444 Walker CS, Hay DL. Reply to comment on: A second trigeminal CGRP receptor: function and expression of the AMY1 receptor. Ann Clin Transl Neurol 2016;3:309-10. [PMID: 27081662 DOI: 10.1002/acn3.294] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
445 Camaré C, Trayssac M, Garmy-Susini B, Mucher E, Sabbadini R, Salvayre R, Negre-Salvayre A. Oxidized LDL-induced angiogenesis involves sphingosine 1-phosphate: prevention by anti-S1P antibody. Br J Pharmacol 2015;172:106-18. [PMID: 25176316 DOI: 10.1111/bph.12897] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
446 Yosten GL, Harada CM, Haddock C, Giancotti LA, Kolar GR, Patel R, Guo C, Chen Z, Zhang J, Doyle TM, Dickenson AH, Samson WK, Salvemini D. GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents. J Clin Invest 2020;130:2587-92. [PMID: 31999650 DOI: 10.1172/JCI133270] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 18.0] [Reference Citation Analysis]
447 Hind WH, England TJ, O'Sullivan SE. Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptors. Br J Pharmacol 2016;173:815-25. [PMID: 26497782 DOI: 10.1111/bph.13368] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 12.5] [Reference Citation Analysis]
448 Wang Y, Kunit T, Ciotkowska A, Rutz B, Schreiber A, Strittmatter F, Waidelich R, Liu C, Stief CG, Gratzke C, Hennenberg M. Inhibition of prostate smooth muscle contraction and prostate stromal cell growth by the inhibitors of Rac, NSC23766 and EHT1864. Br J Pharmacol 2015;172:2905-17. [PMID: 25631101 DOI: 10.1111/bph.13099] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
449 Szebeni J, Fishbane S, Hedenus M, Howaldt S, Locatelli F, Patni S, Rampton D, Weiss G, Folkersen J. Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management. Br J Pharmacol 2015;172:5025-36. [PMID: 26265306 DOI: 10.1111/bph.13268] [Cited by in Crossref: 74] [Cited by in F6Publishing: 62] [Article Influence: 10.6] [Reference Citation Analysis]
450 Yan C, Yang Y, Saito K, Xu P, Wang C, Hinton AO Jr, Yan X, Wu Q, Tong Q, Elmquist JK, Fukuda M, Xu Y. Meta-chlorophenylpiperazine enhances leptin sensitivity in diet-induced obese mice. Br J Pharmacol 2015;172:3510-21. [PMID: 25817043 DOI: 10.1111/bph.13141] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
451 Black SW, Yamanaka A, Kilduff TS. Challenges in the development of therapeutics for narcolepsy. Prog Neurobiol 2017;152:89-113. [PMID: 26721620 DOI: 10.1016/j.pneurobio.2015.12.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
452 Yamamizu K, Hamada Y, Narita M. κ Opioid receptor ligands regulate angiogenesis in development and in tumours. Br J Pharmacol 2015;172:268-76. [PMID: 24417697 DOI: 10.1111/bph.12573] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
453 Green AR, King MV, Shortall SE, Fone KC. The preclinical pharmacology of mephedrone; not just MDMA by another name. Br J Pharmacol 2014;171:2251-68. [PMID: 24654568 DOI: 10.1111/bph.12628] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 5.6] [Reference Citation Analysis]
454 Ning SL, Zheng WS, Su J, Liang N, Li H, Zhang DL, Liu CH, Dong JH, Zhang ZK, Cui M, Hu QX, Chen CC, Liu CH, Wang C, Pang Q, Chen YX, Yu X, Sun JP. Different downstream signalling of CCK1 receptors regulates distinct functions of CCK in pancreatic beta cells. Br J Pharmacol 2015;172:5050-67. [PMID: 26248680 DOI: 10.1111/bph.13271] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.1] [Reference Citation Analysis]
455 Lirk P, Fiegl H, Weber NC, Hollmann MW. Epigenetics in the perioperative period. Br J Pharmacol 2015;172:2748-55. [PMID: 25073649 DOI: 10.1111/bph.12865] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 4.1] [Reference Citation Analysis]
456 Diraddo JO, Miller EJ, Bowman-dalley C, Wroblewska B, Javidnia M, Grajkowska E, Wolfe BB, Liotta DC, Wroblewski JT. Chloride is an Agonist of Group II and III Metabotropic Glutamate Receptors. Mol Pharmacol 2015;88:450-9. [DOI: 10.1124/mol.114.096420] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
457 Cui C, Wang LF, Huang SB, Zhao P, Chen YQ, Wu YB, Qiao CM, Zhao WJ, Shen YQ. Adequate expression of neuropeptide Y is essential for the recovery of zebrafish motor function following spinal cord injury. Exp Neurol 2021;345:113831. [PMID: 34363807 DOI: 10.1016/j.expneurol.2021.113831] [Reference Citation Analysis]
458 Blakeley D, Sykes DA, Ensor P, Bertran E, Aston PJ, Charlton SJ. Simulating the influence of plasma protein on measured receptor affinity in biochemical assays reveals the utility of Schild analysis for estimating compound affinity for plasma proteins. Br J Pharmacol 2015;172:5037-49. [PMID: 26211929 DOI: 10.1111/bph.13263] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
459 Beiranvand F, Zlabinger C, Orr-Urtreger A, Ristl R, Huck S, Scholze P. Nicotinic acetylcholine receptors control acetylcholine and noradrenaline release in the rodent habenulo-interpeduncular complex. Br J Pharmacol 2014;171:5209-24. [PMID: 25041479 DOI: 10.1111/bph.12841] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
460 Lo YC, Tseng YT, Liu CM, Wu BN, Wu SN. Actions of KMUP-1, a xanthine and piperazine derivative, on voltage-gated Na(+) and Ca(2+) -activated K(+) currents in GH3 pituitary tumour cells. Br J Pharmacol 2015;172:5110-22. [PMID: 26276211 DOI: 10.1111/bph.13276] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
461 Kuo A, Wyse BD, Meutermans W, Smith MT. In vivo profiling of seven common opioids for antinociception, constipation and respiratory depression: no two opioids have the same profile. Br J Pharmacol 2015;172:532-48. [PMID: 24641546 DOI: 10.1111/bph.12696] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.8] [Reference Citation Analysis]
462 Al Kury LT, Voitychuk OI, Yang KH, Thayyullathil FT, Doroshenko P, Ramez AM, Shuba YM, Galadari S, Howarth FC, Oz M. Effects of the endogenous cannabinoid anandamide on voltage-dependent sodium and calcium channels in rat ventricular myocytes. Br J Pharmacol 2014;171:3485-98. [PMID: 24758718 DOI: 10.1111/bph.12734] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
463 Carneiro I, Timóteo MA, Silva I, Vieira C, Baldaia C, Ferreirinha F, Silva-Ramos M, Correia-de-Sá P. Activation of P2Y6 receptors increases the voiding frequency in anaesthetized rats by releasing ATP from the bladder urothelium. Br J Pharmacol 2014;171:3404-19. [PMID: 24697602 DOI: 10.1111/bph.12711] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
464 Kargl J, Andersen L, Hasenöhrl C, Feuersinger D, Stančić A, Fauland A, Magnes C, El-Heliebi A, Lax S, Uranitsch S, Haybaeck J, Heinemann A, Schicho R. GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis. Br J Pharmacol 2016;173:142-54. [PMID: 26436760 DOI: 10.1111/bph.13345] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 7.6] [Reference Citation Analysis]
465 Webb SL, Edwards CM. Novel therapeutic targets in myeloma bone disease. Br J Pharmacol 2014;171:3765-76. [PMID: 24750110 DOI: 10.1111/bph.12742] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
466 Sampaio LS, Taveira Da Silva R, Lima D, Sampaio CL, Iannotti FA, Mazzarella E, Di Marzo V, Vieyra A, Reis RA, Einicker-Lamas M. The endocannabinoid system in renal cells: regulation of Na(+) transport by CB1 receptors through distinct cell signalling pathways. Br J Pharmacol 2015;172:4615-25. [PMID: 25537261 DOI: 10.1111/bph.13050] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
467 Ho JC, Lee CH. TRP channels in skin: from physiological implications to clinical significances. Biophysics (Nagoya-shi) 2015;11:17-24. [PMID: 27493510 DOI: 10.2142/biophysics.11.17] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
468 Zhang Y, Simpson-Durand CD, Standifer KM. Nociceptin/orphanin FQ peptide receptor antagonist JTC-801 reverses pain and anxiety symptoms in a rat model of post-traumatic stress disorder. Br J Pharmacol 2015;172:571-82. [PMID: 24666365 DOI: 10.1111/bph.12701] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
469 Andressen KW, Manfra O, Brevik CH, Ulsund AH, Vanhoenacker P, Levy FO, Krobert KA. The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors. Br J Pharmacol 2015;172:3846-60. [PMID: 25884989 DOI: 10.1111/bph.13169] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
470 Woo AY, Song Y, Xiao RP, Zhu W. Biased β2-adrenoceptor signalling in heart failure: pathophysiology and drug discovery. Br J Pharmacol 2015;172:5444-56. [PMID: 25298054 DOI: 10.1111/bph.12965] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
471 Raviprakash N, Manna SK. Short-term exposure to oleandrin enhances responses to IL-8 by increasing cell surface IL-8 receptors. Br J Pharmacol 2014;171:3339-51. [PMID: 24172227 DOI: 10.1111/bph.12493] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
472 Kimura M, Sakai A, Sakamoto A, Suzuki H. Glial cell line-derived neurotrophic factor-mediated enhancement of noradrenergic descending inhibition in the locus coeruleus exerts prolonged analgesia in neuropathic pain. Br J Pharmacol 2015;172:2469-78. [PMID: 25572945 DOI: 10.1111/bph.13073] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
473 Cunha-reis D, Caulino-rocha A, Correia-de-sá P. VIPergic neuroprotection in epileptogenesis: challenges and opportunities. Pharmacological Research 2021;164:105356. [DOI: 10.1016/j.phrs.2020.105356] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
474 Mosher LJ, Frau R, Pardu A, Pes R, Devoto P, Bortolato M. Selective activation of D1 dopamine receptors impairs sensorimotor gating in Long-Evans rats. Br J Pharmacol 2016;173:2122-34. [PMID: 26101934 DOI: 10.1111/bph.13232] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
475 Ruan Y, Böhmer T, Jiang S, Gericke A. The Role of Adrenoceptors in the Retina. Cells 2020;9:E2594. [PMID: 33287335 DOI: 10.3390/cells9122594] [Reference Citation Analysis]
476 Sánchez A, Martínez P, Muñoz M, Benedito S, García-Sacristán A, Hernández M, Prieto D. Endothelin-1 contributes to endothelial dysfunction and enhanced vasoconstriction through augmented superoxide production in penile arteries from insulin-resistant obese rats: role of ET(A) and ET(B) receptors. Br J Pharmacol 2014;171:5682-95. [PMID: 25091502 DOI: 10.1111/bph.12870] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
477 Headrick JP, See Hoe LE, Du Toit EF, Peart JN. Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart. Br J Pharmacol 2015;172:2026-50. [PMID: 25521834 DOI: 10.1111/bph.13042] [Cited by in Crossref: 71] [Cited by in F6Publishing: 64] [Article Influence: 10.1] [Reference Citation Analysis]
478 Vernall AJ, Hill SJ, Kellam B. The evolving small-molecule fluorescent-conjugate toolbox for Class A GPCRs. Br J Pharmacol 2014;171:1073-84. [PMID: 23734587 DOI: 10.1111/bph.12265] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 7.8] [Reference Citation Analysis]
479 Hennenberg M, Acevedo A, Wiemer N, Kan A, Tamalunas A, Wang Y, Yu Q, Rutz B, Ciotkowska A, Herlemann A, Strittmatter F, Stief CG, Gratzke C. Non‐Adrenergic, Tamsulosin‐Insensitive Smooth Muscle Contraction is Sufficient to Replace α 1 ‐Adrenergic Tension in the Human Prostate. Prostate 2017;77:697-707. [DOI: 10.1002/pros.23293] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
480 Jiménez M, Clavé P, Accarino A, Gallego D. Purinergic neuromuscular transmission in the gastrointestinal tract; functional basis for future clinical and pharmacological studies. Br J Pharmacol 2014;171:4360-75. [PMID: 24910216 DOI: 10.1111/bph.12802] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
481 Sykes DA, Riddy DM, Stamp C, Bradley ME, McGuiness N, Sattikar A, Guerini D, Rodrigues I, Glaenzel A, Dowling MR, Mullershausen F, Charlton SJ. Investigating the molecular mechanisms through which FTY720-P causes persistent S1P1 receptor internalization. Br J Pharmacol 2014;171:4797-807. [PMID: 24641481 DOI: 10.1111/bph.12620] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.9] [Reference Citation Analysis]
482 Chen B, Lu D, Fu Y, Zhang J, Huang X, Cao S, Xu D, Bin J, Kitakaze M, Huang Q, Liao Y. Olmesartan prevents cardiac rupture in mice with myocardial infarction by modulating growth differentiation factor 15 and p53. Br J Pharmacol 2014;171:3741-53. [PMID: 24749959 DOI: 10.1111/bph.12736] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
483 Fuenzalida J, Galaz P, Araya KA, Slater PG, Blanco EH, Campusano JM, Ciruela F, Gysling K. Dopamine D1 and corticotrophin-releasing hormone type-2α receptors assemble into functionally interacting complexes in living cells. Br J Pharmacol 2014;171:5650-64. [PMID: 25073922 DOI: 10.1111/bph.12868] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
484 Pagnussat N, Almeida AS, Marques DM, Nunes F, Chenet GC, Botton PH, Mioranzza S, Loss CM, Cunha RA, Porciúncula LO. Adenosine A(2A) receptors are necessary and sufficient to trigger memory impairment in adult mice. Br J Pharmacol 2015;172:3831-45. [PMID: 25939452 DOI: 10.1111/bph.13180] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 7.0] [Reference Citation Analysis]
485 Laprairie RB, Bagher AM, Kelly ME, Denovan-Wright EM. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br J Pharmacol 2015;172:4790-805. [PMID: 26218440 DOI: 10.1111/bph.13250] [Cited by in Crossref: 414] [Cited by in F6Publishing: 398] [Article Influence: 59.1] [Reference Citation Analysis]
486 Shin H, Hong SD, Roh E, Jung SH, Cho WJ, Park SH, Yoon DY, Ko SM, Hwang BY, Hong JT, Heo TY, Han SB, Kim Y. cAMP-dependent activation of protein kinase A as a therapeutic target of skin hyperpigmentation by diphenylmethylene hydrazinecarbothioamide. Br J Pharmacol 2015;172:3434-45. [PMID: 25766244 DOI: 10.1111/bph.13134] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
487 Qiu F, Qiu CY, Cai H, Liu TT, Qu ZW, Yang Z, Li JD, Zhou QY, Hu WP. Oxytocin inhibits the activity of acid-sensing ion channels through the vasopressin, V1A receptor in primary sensory neurons. Br J Pharmacol 2014;171:3065-76. [PMID: 24641084 DOI: 10.1111/bph.12635] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 6.3] [Reference Citation Analysis]
488 Murase R, Kawamura R, Singer E, Pakdel A, Sarma P, Judkins J, Elwakeel E, Dayal S, Martinez-Martinez E, Amere M, Gujjar R, Mahadevan A, Desprez PY, McAllister SD. Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer. Br J Pharmacol 2014;171:4464-77. [PMID: 24910342 DOI: 10.1111/bph.12803] [Cited by in Crossref: 43] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
489 Mijušković A, Kokić AN, Dušić ZO, Slavić M, Spasić MB, Blagojević D. Chloride channels mediate sodium sulphide-induced relaxation in rat uteri. Br J Pharmacol 2015;172:3671-86. [PMID: 25857480 DOI: 10.1111/bph.13161] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
490 Malik M, Rangel-Barajas C, Sumien N, Su C, Singh M, Chen Z, Huang RQ, Meunier J, Maurice T, Mach RH, Luedtke RR. The effects of sigma (σ1) receptor-selective ligands on muscarinic receptor antagonist-induced cognitive deficits in mice. Br J Pharmacol 2015;172:2519-31. [PMID: 25573298 DOI: 10.1111/bph.13076] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
491 Zhang LS, Wang YJ, Ju YY, Zan GY, Xu C, Hong MH, Wang YH, Chi ZQ, Liu JG. Role for engagement of β-arrestin2 by the transactivated EGFR in agonist-specific regulation of δ receptor activation of ERK1/2. Br J Pharmacol 2015;172:4847-63. [PMID: 26211551 DOI: 10.1111/bph.13254] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
492 Blackshaw LA. Transient receptor potential cation channels in visceral sensory pathways. Br J Pharmacol 2014;171:2528-36. [PMID: 24641218 DOI: 10.1111/bph.12641] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
493 Adamson Barnes NS, Mitchell VA, Kazantzis NP, Vaughan CW. Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model. Br J Pharmacol 2016;173:77-87. [PMID: 26398331 DOI: 10.1111/bph.13337] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
494 Luo Q, Sun Y, Gong FY, Liu W, Zheng W, Shen Y, Hua ZC, Xu Q. Blocking initial infiltration of pioneer CD8(+) T-cells into the CNS via inhibition of SHP-2 ameliorates experimental autoimmune encephalomyelitis in mice. Br J Pharmacol 2014;171:1706-21. [PMID: 24372081 DOI: 10.1111/bph.12565] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
495 Thompson GL, Kelly E, Christopoulos A, Canals M. Novel GPCR paradigms at the μ-opioid receptor. Br J Pharmacol 2015;172:287-96. [PMID: 24460711 DOI: 10.1111/bph.12600] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 5.8] [Reference Citation Analysis]
496 Trentin PG, Ferreira TP, Arantes AC, Ciambarella BT, Cordeiro RS, Flower RJ, Perretti M, Martins MA, Silva PM. Annexin A1 mimetic peptide controls the inflammatory and fibrotic effects of silica particles in mice. Br J Pharmacol 2015;172:3058-71. [PMID: 25659822 DOI: 10.1111/bph.13109] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]